da lunedì a venerdì: 7:00 – 19:30 – Sabato: 7:00 – 12:30 – Domenica: chiuso
da lunedì a venerdì: 7:00 – 19:30 – Sabato: 7:00 – 12:30 – Domenica: chiuso – Variazione orari
The analyses performed in Service are sent to Cerba Healthcare Italia.
regional code | Description | Performed in-house or in service | METHOD | MACHINE | UNIT OF MEASURE | Reference values for men | women's reference values | reporting days | PP Gallarate | PP Somma | PP Cavaria | PP Bulgarograsso | PP Cinisello |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
90.04.5 | TRANSAMINASE GPT (ALT) | In-House | IFCC Without PYRIDOXALPHOSPHATE | AU 480 BECKMAN | UI/L | 0 - 40 | 0 - 40 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.05.1 | ALBUMIN IN URINE | In-House | Immunoturbidimetric | AU 480 BECKMAN | mg/L | <20.0 | <20.0 | 2 | Yes | Yes | Yes | Yes | Yes | |
90.05.1 | ALBUMIN IN URINE 24 HOURS | In-House | Immunoturbidimetric | AU 480 BECKMAN | mg/gcreatinina/24h | <30.0 | <30.0 | 2 | Yes | Yes | Yes | Yes | Yes | |
90.05.1 | SERUM ALBUMIN | In-House | Colorimetric Bromocresol Green | AU 480 BECKMAN | g/L | < 14 years : 38-54 > 14 years: 35-52 | < 14 years : 38-54 > 14 years: 35-52 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.06.4 | ALPHA AMYLASE | In-House | IFCC Blocked Substrate 4-Nitrophenyl-Maltoheptaoside Ethylidene-Blocked | AU 480 BECKMAN | U/L | 0 - 100 | 0 - 100 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.09.2 | GOT TRANSAMINATION (AST) | In-House | IFCC Without PYRIDOXALPHOSPHATE | AU 480 BECKMAN | UI/L | 0 - 35 | 0 - 35 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.10.5 | TOTAL BILIRUBIN AND REFLEX | TOTAL BILIRUBIN | In-House | Colorimetric Diazoreagent, 3,5-dichlorophenyldiation (DPD) | AU 480 BECKMAN | mg/dl | 0.10-1.10 | 0.10-1.10 | 1 | Yes | Yes | Yes | Yes | Yes |
DIRECT BILIRUBIN | In-House | Colorimetric Diazoreagent, 3,5-dichlorophenyldiation (DPD) | AU 480 BECKMAN | mg/dl | <0.35 | <0.35 | 1 | Yes | Yes | Yes | Yes | |||
90.11.4 | TOTAL CALCIUM | In-House | Colorimetric Arsenazo III | AU 480 BECKMAN | mg/dl | < 12 years: 8.4 - 10 12-18 years 8.1 -10 > 18 years: 8.1 - 11 > 60 years 8.8 - 10,2 | < 12 years: 8.4 - 10 12-18 years 8.1 -10 > 18 years: 8.1 - 11 > 60 years 8.8 - 10,2 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.13.3 | SERUM CHLORIDE | In-House | Indirect Potentiometry I.S.E. | AU 480 BECKMAN | mEq/L | 96 - 110 | 96 - 110 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.13.5 | VITAMIN B12 | In-House | Chemiluminescence immunoassay with competitive binding | ACCESS 2 BECKMAN | ng/L | 180 - 914 | 180 - 914 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.13.B | LDL CHOLESTEROL (INDIRECT CALCULATION) | In-House | Calculation | 1 | Yes | Yes | Yes | Yes | Yes | |||||
90.13.C | LDL CHOLESTEROL (DIRECT DETERMINATION) | In-House | Cholesterol Oxidase-Peroxidase (CHOD-POD) Enzyme in Homogeneous Phase for Elimination | AU 480 BECKMAN | mg/dl | < 130 | < 130 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.14.1 | COLESTEROLO HDL | In-House | Cholesterol Oxidase-Peroxidase (CHOD-POD) Enzyme in Homogeneous Phase for Elimination | AU 480 BECKMAN | mg/dl | > 40 | > 40 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.14.3 | TOTAL CHOLESTEROL | In-House | Cholesterol Oxidase-Peroxidase (CHOD-POD) Enzyme in Homogeneous Phase for Elimination | AU 480 BECKMAN | mg/dl | 140 - 200 | 140 - 200 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.14.4 | CHOLIESTERASE (PSEUDO-CHE) | In-House | Substrate Butyrylthiocholine | AU 480 BECKMAN | U/L | 4600 -12000 | 3900-10800 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.15.4 | CREATININCHINASI ( CPK O CK) | In-House | Optimized IFCC method with N-acetylcysteine (NAC) | AU 480 BECKMAN | U/L | 20 - 200 | 1 | Yes | Yes | Yes | Yes | Yes | ||
90.16.3 | CREATININE | In-House | Colorimetric Alkaline Picrate (JAFFE) | AU 480 BECKMAN | mg/dl | 0,50 - 1,30 | 1 | Yes | Yes | Yes | Yes | Yes | ||
90.16.3 | CREATININE IN URINE | In-House | Colorimetric Alkaline Picrate (JAFFE) | AU 480 BECKMAN | mg/dl | 28 - 217,0 | 1 | Yes | Yes | Yes | Yes | Yes | ||
90.16.3 | CREATININE IN URINE 24 H | In-House | Colorimetric Alkaline Picrate (JAFFE) | AU 480 BECKMAN | g/24H | 1,0 - 1,5 | 1 | Yes | Yes | Yes | Yes | Yes | ||
90.16.4 | CLEARANCE CREATININE | In-House | Colorimetric Alkaline Picrate (JAFFE) | AU 480 BECKMAN | ml/min | 90 - 180 | 1 | Yes | Yes | Yes | Yes | Yes | ||
90.19.2 | ESTRADIOL (E2) | In-House | Chemiluminescence immunoassay with competitive binding | ACCESS 2 BECKMAN | ng/L | 1 | Yes | Yes | Yes | Yes | Yes | |||
90.21.4 | FAECES OCCULT BLOOD | In-House | Latex immunoturbidimetric | OC- Sensor IO DASIT | ng/ml | < 50 negative 50-100 weak positive > =100 POSITIVE | < 50 negative 50-100 Debole POSITIVE > =100 POSITIVE | 2 | Yes | Yes | Yes | Yes | Yes | |
90.22.3 | FERRITIN | In-House | 2-site chemiluminescence immunoassay. | ACCESS 2 BECKMAN | ng/ml | 30 - 300 | 10 - 280 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.22.5 | IRON | In-House | Colorimetric Tripyridyl-triazine (TPTZ) | AU 480 BECKMAN | mg/dl | 60 - 160 | 40 - 145 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.23.2 | FOLATE | In-House | Chemiluminescence immunoassay with competitive binding | ACCESS 2 BECKMAN | mg/L | 3.0-17 | 3.0-17 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.23.3 | FSH (FOLLITROPIN) | In-House | 2-phase chemiluminescence immunoassay. | ACCESS 2 BECKMAN | UI/L | 0.7 - 11.1 | follicular phase: 2.8 - 11.3_x000D_ ovulation peak: 3.0 - 14.4_x000D_ luteal phase: 1.2 - 9.0_x000D_ menopause: 21.7-153.0 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.23.5 | ALKALINE PHOSPHATASI (ALP) | In-House | IFCC p-Nitrophenylphosphate (pNNP), amino-methyl-propanol (AMP) buffer | AU 480 BECKMAN | U/L | < 17 years : 40-350 > 17 years : 30-120 | < 17 years : 40-350 > 17 years : 30-120 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.24.3 | INORGANIC PHOSPHATE (Phosphorus) | In-House | Colorimetric Phosphomolybdate UV 340 nm | AU 480 BECKMAN | mg/dl | 2.5-4.7 | 2.5-4.7 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.25.5 | GAMMA GLUTAMYL TRANSPEPTIDE (GAMMA GT) | In-House | IFCC Optimized Substrate G-glutamyl 3-carboxy-4-nitroanilide | AU 480 BECKMAN | U/L | 0-55 | 0 - 40 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.26.5 | GLUCOSE CHARGE CURVE WITH 3 DETERMINATIONS | In-House | Enzyme Hexokinase | AU 480 BECKMAN | mg/dl | 70 - 110 | 70 - 110 | 1 | Yes | No | No | No | No | |
90.26.5 | GLUCOSE CHARGE CURVE WITH 2 DETERMINATIONS | In-House | Enzyme Hexokinase | AU 480 BECKMAN | mg/dl | 70 - 110 | 70 - 110 | 1 | Yes | No | No | No | No | |
90.26.5 | GLUCOSE CHARGE CURVE WITH 4 DETERMINATIONS | In-House | Enzyme Hexokinase | AU 480 BECKMAN | mg/dl | 70 - 110 | 70 - 110 | 1 | Yes | No | No | No | No | |
90.26.5 | GLUCOSE CHARGE CURVE WITH 6 DETERMINATIONS | In-House | Enzyme Hexokinase | AU 480 BECKMAN | mg/dl | 70 - 110 | 70 - 110 | 1 | Yes | No | No | No | No | |
90.27.1 | PRE-PRANDIAL GLUCOSE | In-House | Enzyme Hexokinase | AU 480 BECKMAN | mg/dl | 70 - 110 | 70 - 110 | 1 | Yes | No | No | No | No | |
90.27.1 | POST-PRANDIAL GLUCOSE | In-House | Enzyme Hexokinase | AU 480 BECKMAN | mg/dl | 70 - 110 | 70 - 110 | 1 | Yes | No | No | No | No | |
90.27.1 | GLUCOSE IN URINE | In-House | Enzyme Hexokinase | AU 480 BECKMAN | mg/dl | 8 | Yes | Yes | Yes | Yes | Yes | |||
90.27.1 | GLUCOSE (GLYCEMIA) | In-House | Enzyme Hexokinase | AU 480 BECKMAN | mg/dl | 70 - 110 | 70 - 110 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.27.3 | PREGNANCY TEST-URINARY CHORIONIC GONADOTROPIN | In-House | Immunochromatographic | QUALITATIVO | negative | negative | 1 | Yes | Yes | Yes | Yes | Yes | ||
90.27.5 | CHORIONIC GONADOTROPIN (WHOLE BETA MOLECULE SUBUNIT) BETA HCG | In-House | Sequential chemiluminescence immunoassay. | ACCESS 2 BECKMAN | UI/L | <2.6 | Post menopause < 7_x000D_ pre menopause < 5_x000D_ pregnant: 3rd week 5.8 - 71.2 ; 4th week 9.5 - 750;_x000D_ 5th week 217 - 7138; 6th week 158 - 31795;_x000D_ 7th week 3697 - 163563; 8th week 32065 - 149571;_x000D_ 9th week 63803 - 151410;10th Sept. 46509 - 186977;_x000D_ 12th week 27832 - 210612; 14th Sept. 13950 - 62530;_x000D_ 15th Sept. 12039 - 70971;16th week 9040 - 56451;_x000D_ 17th Sept. 8175 - 55868; 18th Sept. 8099 - 58176. | 1 | Yes | Yes | Yes | Yes | Yes | |
90.28.1 | GLYCATED HEMOGLOBIN | In-House | Capillary | SEBIA MINICAP FLEX PIERCING | mmol/mol | 20 - 42 | 20 - 42 | 2 | Yes | Yes | Yes | Yes | Yes | |
90.29.2 | LACTATE DEHYDROGENASE (LDH) | In-House | Optimized IFCC Lactate-Pyruvate method | AU 480 BECKMAN | U/L | 211 - 423 | 211 - 423 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.30.2 | LIPASE | In-House | Substrate 1,2-Diglyceride | AU 480 BECKMAN | U/L | 10 - 60 | 10 - 60 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.32.3 | LH (LUTEOTROPIN) | In-House | 2-phase chemiluminescence immunoassay. | ACCESS 2 BECKMAN | UI/L | 1.7 - 8.6 | follicular phase 2.4 - 12.6;_x000D_ ovulatory phase 14.0 - 95.6;_x000D_ luteal phase 1.0 - 11.4;_x000D_ post menopause 7.7 - 58.5 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.32.5 | TOTAL MAGNESIUM | In-House | Colorimetric Xylidyl Blue | AU 480 BECKMAN | mg/dl | < 20 years: 1,3 - 2,5 > 20 years : 1,6 - 2,5 | < 20 years: 1,3 - 2,5 > 20 years : 1,6 - 2,5 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.33.4 | 24-HOUR URINE MICROALBUMINURIA | In-House | Immunoturbidimetric | AU 480 BECKMAN | mg/L | <20.0 | <20.0 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.33.4 | MICROALBUMINURIA IN URINE | In-House | Immunoturbidimetric | AU 480 BECKMAN | mg/gcreatinina/24h | <30.0 | <30.0 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.37.4 | POTASSIUM | In-House | Indirect Potentiometry I.S.E. | AU 480 BECKMAN | mEq/L | 3.6-5.2 | 3.6-5.2 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.38.2 | PROLACTIN | In-House | Single-step simultaneous chemiluminescence immunoassay | ACCESS 2 BECKMAN | ng/ml | 2.5 - 17.0 | 1.9 - 25.0 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.38.4 | PROTEIN ELECTROPHORESIS | ALBUMINA % | In-House | Capillary | SEBIA MINICAP FLEX PIERCING | % | 54 - 66 | 54 - 66 | 2 | Yes | Yes | Yes | Yes | Yes |
ALFA 1 GLOBULINE % | In-House | Capillary | SEBIA MINICAP FLEX PIERCING | % | 3 - 6 | 3 - 6 | 2 | Yes | Yes | Yes | Yes | Yes | ||
ALFA 2 GLOBULINE % | In-House | Capillary | SEBIA MINICAP FLEX PIERCING | % | 7 - 10 | 7 - 10 | 2 | Yes | Yes | Yes | Yes | Yes | ||
BETA 1 GLOBULINE % | In-House | Capillary | SEBIA MINICAP FLEX PIERCING | % | 4.7 - 7.2 | 4.7 - 7.2 | 2 | Yes | Yes | Yes | Yes | Yes | ||
BETA 2 GLOBULINE % | In-House | Capillary | SEBIA MINICAP FLEX PIERCING | % | 3.2 - 6.5 | 3.2 - 6.5 | 2 | Yes | Yes | Yes | Yes | Yes | ||
GAMMA GLOBULINE % | In-House | Capillary | SEBIA MINICAP FLEX PIERCING | % | 12 - 20 | 12 - 20 | 2 | Yes | Yes | Yes | Yes | Yes | ||
RAPPORTO ALB/GLOBULINE | In-House | Capillary | SEBIA MINICAP FLEX PIERCING | rapporto | 1.10 - 2.40 | 1.10 - 2.40 | 2 | Yes | Yes | Yes | Yes | Yes | ||
ALBUMINA | In-House | Capillary | SEBIA MINICAP FLEX PIERCING | g/dl | 3.35 - 4.75 | 3.35 - 4.75 | 2 | Yes | Yes | Yes | Yes | Yes | ||
ALFA 1 GLOBULINE | In-House | Capillary | SEBIA MINICAP FLEX PIERCING | g/dl | 0.21 - 0.43 | 0.21 - 0.43 | 2 | Yes | Yes | Yes | Yes | Yes | ||
ALFA 2 GLOBULINE | In-House | Capillary | SEBIA MINICAP FLEX PIERCING | g/dl | 0.50 - 0.72 | 0.50 - 0.72 | 2 | Yes | Yes | Yes | Yes | Yes | ||
BETA 1 GLOBULINE | In-House | Capillary | SEBIA MINICAP FLEX PIERCING | g/dl | 0.34 - 0.52 | 0.34 - 0.52 | 2 | Yes | Yes | Yes | Yes | Yes | ||
BETA 2 GLOBULINE | In-House | Capillary | SEBIA MINICAP FLEX PIERCING | g/dl | 0.23 - 0.47 | 0.23 - 0.47 | 2 | Yes | Yes | Yes | Yes | Yes | ||
GAMMA GLOBULINE | In-House | Capillary | SEBIA MINICAP FLEX PIERCING | g/dl | 0.86 - 1.44 | 0.86 - 1.44 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.38.5 | PROTEINS | In-House | Colorimetric Biuret reaction | AU 480 BECKMAN | g/dl | 6.0-8.0 | 6.0-8.0 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.40.4 | SODIUM | In-House | Indirect Potentiometry I.S.E. | AU 480 BECKMAN | mEq/L | 134 - 146 | 134 - 146 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.41.8 | REFLEX THYROTROPIN (TSH-R) TSH, INCLUDING POSSIBLE DOSAGE OF FT3 AND FT4 | In-House | 2-site chemiluminescence immunoassay. | ACCESS 2 BECKMAN | mUI/L | 0.45 - 4.00 The reflex TSH requires the execution of FT4 only for TSH values > 4.0 and TSH < 0.45 in which FT4 has interpretative value. The execution of FT3 is required for TSH values <0.45 and simultaneously FT4 < 18.4 pmol/L ( 1.24 ng/dl). | 0.45 - 4.00 The reflex TSH requires the execution of FT4 only for TSH values > 4.0 and TSH < 0.45 in which FT4 has interpretative value. The execution of FT3 is required for TSH values <0.45 and simultaneously FT4 < 18.4 pmol/L ( 1.24 ng/dl). | 1 | Yes | Yes | Yes | Yes | Yes | |
90.42.1 | TSH (THYROTROPIN) | datiii??? | In-House | 2-site chemiluminescence immunoassay. | ACCESS 2 BECKMAN | mUI/L | 0.45 - 4.00 | 0.45 - 4.00 | 1 | Yes | Yes | Yes | Yes | Yes |
90.42.3 | FT4 (FREE TYROSINE) | In-House | Sequential chemiluminescence immunoassay. | ACCESS 2 BECKMAN | ng/L | 0.54-1.25 | 0.54-1.25 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.42.4 | TRANSFERRIN FERROLIGAND CAPACITY | In-House | Calculation | 1 | Yes | Yes | Yes | Yes | Yes | |||||
90.42.5 | TRANSFERRIN | In-House | Immunoturbidimetric | AU 480 BECKMAN | mg/dl | 180 - 260 | 180 - 260 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.43.2 | TRIGLYCERIDES | In-House | Enzyme Glycerol Phosphate Oxidase-Peroxidase (GPO-POD) | AU 480 BECKMAN | mg/dl | < 200 | < 200 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.43.3 | FT3 (FREE TRYODTHYRONINE) | In-House | Chemiluminescence immunoassay with competitive binding | ACCESS 2 BECKMAN | pmol/L | 2.5 - 5 | 2.5 - 5 | 2 | Yes | Yes | Yes | Yes | Yes | |
90.43.5 | URIC ACID | In-House | Uricase-Peroxidase Enzyme (colorimetric) | AU 480 BECKMAN | mg/dl | 2.4 -7.2 | 2.0-6.5 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.44.1 | UREA | In-House | Urease-glutamate dehydrogenase (GLDH) enzyme Uv | AU 480 BECKMAN | mg/dl | 10 - 55 | 10 - 55 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.44.3 | URINE CHEMICAL, PHYSICAL AND MICROSCOPIC EXAMINATION | COLOR AND APPEARANCE | In-House | Optical | VELOCITY BECKMAN | 1 | Yes | Yes | Yes | Yes | Yes | |||
OWN WEIGHT | In-House | REFLECTANCE | VELOCITY BECKMAN | 1 | Yes | Yes | Yes | Yes | Yes | |||||
PH | In-House | Optical | VELOCITY BECKMAN | 1 | Yes | Yes | Yes | Yes | Yes | |||||
GLUCOSE | In-House | Optical | VELOCITY BECKMAN | g/L | < 0,02 | < 0,02 | 1 | Yes | Yes | Yes | Yes | Yes | ||
PROTEINS | In-House | Optical | VELOCITY BECKMAN | mg/dL | < 15 | < 15 | 1 | Yes | Yes | Yes | Yes | Yes | ||
HAEMOGLOBIN | In-House | Optical | VELOCITY BECKMAN | mg/dL | < 0,03 | < 0,03 | 1 | Yes | Yes | Yes | Yes | Yes | ||
LEUKOCYTES | In-House | Optical | VELOCITY BECKMAN | n°/uL | < 20 | < 20 | 1 | Yes | Yes | Yes | Yes | Yes | ||
KETONE BODIES | In-House | Optical | VELOCITY BECKMAN | mg/dL | < 2 | < 2 | 1 | Yes | Yes | Yes | Yes | Yes | ||
BILIRUBIN | In-House | Optical | VELOCITY BECKMAN | mg/dL | < 0,05 | < 0,05 | 1 | Yes | Yes | Yes | Yes | Yes | ||
UROBILINOGEN | In-House | Optical | VELOCITY BECKMAN | mg/dL | < 1,0 | < 1,0 | 1 | Yes | Yes | Yes | Yes | Yes | ||
NITRITES | In-House | Optical | VELOCITY BECKMAN | Absent | Absent | 1 | Yes | Yes | Yes | Yes | Yes | |||
SEDIMENT | In-House | Digital Microscopy applied to fluidic system | IQ 200 ELITE BECKMAN | 1 | Yes | Yes | Yes | Yes | Yes | |||||
90.44.5 | VITAMIN D (25 OH) | In-House | 2-site chemiluminescence immunoassay. | ACCESS 2 BECKMAN | ng/ml | < 20 DEFICIENCY; 21-29 INSUFFICIENCY; > 30 RECOMMENDED | < 20 DEFICIENCY; 21-29 INSUFFICIENCY; > 30 RECOMMENDED | 1 | Yes | Yes | Yes | Yes | Yes | |
90.56.3 | CEA (EMBRYONIC CARCINOGENIC ANTIGEN) | In-House | 2-site chemiluminescence immunoassay. | ACCESS 2 BECKMAN | ng/mL | < 5.5 If smokers < 4 If non-smokers | < 5.5 If smokers < 4 If non-smokers | 1 | Yes | Yes | Yes | Yes | Yes | |
90.56.9 | PSA ( ANTIG. PROSTATE-SPECIFIC) INCLU. EVENT. FREE FRACTION DOSAGE | In-House | 2-site chemiluminescence immunoassay. | ACCESS 2 BECKMAN | ng/mL | < 4.00 the reflected PSA requires the execution of the FREE PSA only for PSA values between 4.00 and 10.0 in which the FPSA/PSA ratio has interpretative value. | 1 | Yes | Yes | Yes | Yes | Yes | ||
90.57.5 | FUNCTIONAL ANTITHROMBIN III | In-House | Photo-optical detection of transmitted light | Sysmex-CA 650 | % | 70 - 130 | 70 - 130 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.61.4 | D-DIMER BY EIA | In-House | Latex turbidimetric | Sysmex-CA 650 | ng/ml | < 350 | < 350 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.62.2 | COMPLETE BLOOD COUNT WITH FORMULA | LEUKOCYTES | In-House | Flow cytometry | Symex XN 1000 | 10^3/uL | 4.0-11.30 | 4.0-11.30 | 1 | Yes | Yes | Yes | Yes | Yes |
ERYTHROCYTES | In-House | Continuous Flow Counting | Symex XN 1000 | 10^6/uL | 4.52 - 5.90 | 4.10 - 5.10 | 1 | Yes | Yes | Yes | Yes | Yes | ||
HAEMOGLOBIN | In-House | S.L.S Sodio Lauril Solfato | Symex XN 1000 | g/dL | 13.0 - 17.5 | 12.0 - 15.3 | 1 | Yes | Yes | Yes | Yes | Yes | ||
EMATOCRITO (HCT) | In-House | Continuous Flow Counting | Symex XN 1000 | % | 40.0 - 50.0 | 36.0 - 45.0 | 1 | Yes | Yes | Yes | Yes | Yes | ||
MEAN CORPUSCULAR VOLUME (MCV) | In-House | Continuous Flow Counting | Symex XN 1000 | fL | 80.0 - 98.0 | 80.0 - 98.0 | 1 | Yes | Yes | Yes | Yes | Yes | ||
MEAN CORPUSCULAR HEMOGLOBIA (MCH) | In-House | Continuous Flow Counting | Symex XN 1000 | pg | 25.0 - 33.2 | 25.0 - 33.2 | 1 | Yes | Yes | Yes | Yes | Yes | ||
MEAN HB CONCENTRATION (MCHC) | In-House | Continuous Flow Counting | Symex XN 1000 | g/dL | 32.4 - 37.0 | 32.4 - 37.0 | 1 | Yes | Yes | Yes | Yes | Yes | ||
DISTRIBUTION OF THE VOLUME OF BLOOD PRESSURE (RDW) | In-House | Continuous Flow Counting | Symex XN 1000 | % | 11.6 - 15.7 | 11.6 - 15.7 | 1 | Yes | Yes | Yes | Yes | Yes | ||
PLATELETS | In-House | Continuous Flow Counting | Symex XN 1000 | 10^3/uL | 150 - 450 | 150 - 450 | 1 | Yes | Yes | Yes | Yes | Yes | ||
LEUKOCYTE FORMULA | NETROPHIC | In-House | Calculation | Symex XN 1000 | % | 43.0 - 65.0 | 43.0 - 65.0 | 1 | Yes | Yes | Yes | Yes | Yes | |
LYMPHOCYTES | In-House | Calculation | Symex XN 1000 | % | 20.0 - 46.0 | 20.0 - 46.0 | 1 | Yes | Yes | Yes | Yes | Yes | ||
MONOCYTES | In-House | Calculation | Symex XN 1000 | % | 2.0 - 10.0 | 2.0 - 10.0 | 1 | Yes | Yes | Yes | Yes | Yes | ||
EOSINOPHILIC | In-House | Calculation | Symex XN 1000 | % | 0.0 - 6.0 | 0.0 - 6.0 | 1 | Yes | Yes | Yes | Yes | Yes | ||
BASOPHILES | In-House | Calculation | Symex XN 1000 | % | 0.0 - 1.5 | 0.0 - 1.5 | 1 | Yes | Yes | Yes | Yes | Yes | ||
NEUTROPHILS | In-House | Continuous Flow Counting | Symex XN 1000 | 10^3/uL | 1.90 - 7.50 | 1.90 - 7.50 | 1 | Yes | Yes | Yes | Yes | Yes | ||
LYMPHOCYTES | In-House | Continuous Flow Counting | Symex XN 1000 | 10^3/uL | 0.80 - 4.20 | 0.80 - 4.20 | 1 | Yes | Yes | Yes | Yes | Yes | ||
MONOCYTES | In-House | Continuous Flow Counting | Symex XN 1000 | 10^3/uL | 0.26 - 1.30 | 0.26 - 1.30 | 1 | Yes | Yes | Yes | Yes | Yes | ||
EOSINOPHILIC | In-House | Continuous Flow Counting | Symex XN 1000 | 10^3/uL | 0.00 - 0.70 | 0.00 - 0.70 | 1 | Yes | Yes | Yes | Yes | Yes | ||
BASOPHILES | In-House | Continuous Flow Counting | Symex XN 1000 | 10^3/uL | 0.00 - 0.10 | 0.00 - 0.10 | 1 | Yes | Yes | Yes | Yes | Yes | ||
NRBC% | In-House | Calculation | Symex XN 1000 | % | 0.0 - 1.0 | 0.0 - 1.0 | 1 | Yes | Yes | Yes | Yes | Yes | ||
IG% | In-House | Calculation | Symex XN 1000 | % | 0 - 9 | 0 - 9 | 1 | Yes | Yes | Yes | Yes | Yes | ||
90.64.2 | RHEUMATOID FACTOR (RHEUMA TEST) | In-House | Latex immunoturbidimetric | AU 480 BECKMAN | IU/mL | < 18 | < 18 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.69.2 | IMMUNOFIXATION | In-House | Capillary | SEBIA MINICAP FLEX PIERCING | 4 | Yes | Yes | Yes | Yes | Yes | ||||
90.72.3 | QUANTITATIVE ASSAY | In-House | Latex immunoturbidimetric | AU 480 BECKMAN | mg/L | < 5 | < 5 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.75.4 | PROTHROMBIN TIME (PT) | INR | In-House | Photo-optical detection of transmitted light | Sysmex-CA 650 | rapporto | 0.78 - 1.18 therapeutic range: 2.00-4.00 | 0.78 - 1.18 therapeutic range: 2.00-4.00 | 1 | Yes | Yes | Yes | Yes | Yes |
ATTIVITA' DI PROTROMBINA | In-House | Photo-optical detection of transmitted light | Sysmex-CA 650 | % | > 70 | > 70 | 1 | Yes | Yes | Yes | Yes | Yes | ||
SECONDI | In-House | Photo-optical detection of transmitted light | Sysmex-CA 650 | Sec | Yes | Yes | Yes | Yes | Yes | |||||
90.76.1 | PARTIAL THROMBOPLASTIN TIME (PTT) | SECONDI | In-House | Colorimetric | Sysmex-CA 650 | Sec | 20 - 40 | 20 - 40 | 1 | Yes | Yes | Yes | Yes | Yes |
90.76.1 | PARTIAL THROMBOPLASTIN TIME (PTT) | RATIO | In-House | Colorimetric | Sysmex-CA 650 | rapporto | 0.80 - 1.20 | 0.80 - 1.20 | 1 | Yes | Yes | Yes | Yes | Yes |
90.65.5 | FIBRINOGEN FUNCTION | In-House | Photo-optical detection of transmitted light | Sysmex-CA 650 | mg/dL | 150 - 450 | 150 - 450 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.82.5 | BLOOD CELL SEDIMENTATION RATE (ESR) | In-House | Modified Westergreen Optician. | VES MATIC CUBE 30 TOUCH | mm/h | 3.0 -20 | 3.0 -20 | 1 | Yes | Yes | Yes | Yes | Yes | |
90.94.2 | INTERMEDIATE URINE CULTURE INCL. POSSIBLE IDEN/SUSCEPTIBILITY | In-House | Cultivation on Plate | Colturale | 3 | Yes_x000D_ It does not take place on Saturdays and pre-holidays | Yes_x000D_ It does not take place on Saturdays and pre-holidays | Yes_x000D_ It does not take place on Saturdays and pre-holidays | Yes_x000D_ It does not take place on Saturdays and pre-holidays | Yes_x000D_ It does not take place on Saturdays and pre-holidays |
||||
90.94.2 | URINE CULTURE FROM SINGLE CATHETERIZATION INCL. POSSIBLE IDEN/SUSCEPTIBILITY | In-House | Cultivation on Plate | Colturale | 3 | Yes_x000D_ It does not take place on Saturdays and pre-holidays | Yes_x000D_ It does not take place on Saturdays and pre-holidays | Yes_x000D_ It does not take place on Saturdays and pre-holidays | Yes_x000D_ It does not take place on Saturdays and pre-holidays | Yes_x000D_ It does not take place on Saturdays and pre-holidays |
||||
90.94.2 | URINE CULTURE FROM INDWELLING CATHETER INCL. POSSIBLE IDEN/SUSCEPTIBILITY | In-House | Cultivation on Plate | Colturale | 3 | Yes_x000D_ It does not take place on Saturdays and pre-holidays | Yes_x000D_ It does not take place on Saturdays and pre-holidays | Yes_x000D_ It does not take place on Saturdays and pre-holidays | Yes_x000D_ It does not take place on Saturdays and pre-holidays | Yes_x000D_ It does not take place on Saturdays and pre-holidays |
||||
90.94.2 | URINE CULTURE FROM BAG INCL. IDEN/SUSCEPTIBILITY TEST | In-House | Cultivation on Plate | Colturale | 3 | Yes_x000D_ It does not take place on Saturdays and pre-holidays | Yes_x000D_ It does not take place on Saturdays and pre-holidays | Yes_x000D_ It does not take place on Saturdays and pre-holidays | Yes_x000D_ It does not take place on Saturdays and pre-holidays | Yes_x000D_ It does not take place on Saturdays and pre-holidays |
||||
90.01.2 | 17-ALFA-OH PROGESTERONE (17-OH-P) | SERVICE | Chemiluminescence | ug/L | 1 month to 1 year 0.79-_x000D_ 16.71 1 year to 13 years_x000D_ <2.28 13 years to 120_x000D_ years 0.29-2.06 | 1 month to 1 year 0.79-_x000D_ 16.71 1 year to 13 years_x000D_ <2.28 13 years to 120_x000D_ years female gender not_x000D_ pregnant Follicular phase <1.05 Ovulation phase 0.13-1.46 Luteal phase 0.27-2.41_x000D_ Postmenopause <0.91_x000D_ Pregnancy End of III_x000D_ trimester 2.24-9.30 | 3 | Yes | Yes | Yes | Yes | Yes | ||
90.01.5 | TOTAL BILE ACIDS | SERVICE | Enzymatic-colorimetric | umol/L | <10.0 | <10.0 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.02.2 | CITRIC ACID -URINE | SERVICE | Enzymatic | g/L | 0.3-1.8 | 0.3-1.8 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.02.2 | CITRIC ACID -URINE 24H | SERVICE | Enzymatic | g/24h diuresi: mL | 0.24-2.5 | 0.4-2.5 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.02.5 | LACTIC ACID | SERVICE | Enzymatic-colorimetric | mg/dL | 4.5-19.8 | 4.5-19.8 | 4 | Yes | Yes | Yes | Yes | Yes | ||
90.43.5 | URIC ACID IN URINE | SERVICE | Enzymatic | g/L | 0.4-1 | 0.4-1 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.43.5 | URIC ACID IN 24-HOUR URINE | SERVICE | Enzymatic | mg/24h | 250-750 | 250-750 | 2 | Yes | Yes | Yes | Yes | Yes | ||
91.12.8 | ADENOVIRUS AG -FECI | SERVICE | Immunochromatographic | 2 | Yes | Yes | Yes | Yes | Yes | |||||
90.04.1 | ADH VASOPRESSIN - SOA | SERVICE | RIA | mL | <3 | <3 | 22 | |||||||
90.05.2 | ALDOLASIS | SERVICE | Enzymatic | U/L | < 7.6 | < 7.6 | 3 | Yes | Yes | Yes | Yes | Yes | ||
90.05.3 | ALDOSTERONE | SERVICE | Chemiluminescence | ng/L | 25-390 | 25-390 | 3 | Yes | Yes | Yes | Yes | Yes | ||
90.05.3 | ALDOSTERONE IN ORTHOSTATISM | SERVICE | Chemiluminescence | ng/L | 25-390 | 25-390 | 3 | Yes_x000D_ Only by Reservation | No | No | No | No | ||
90.05.3 | ALDOSTERONE -URINE 24H | SERVICE | Chemiluminescence | ug/24h Diuresi: mL | 1,2-28.1 | 1,2-28.1 | 3 | Yes | Yes | Yes | Yes | Yes | ||
90.05.4 | ALFA 1 ANTITRIX | SERVICE | Immunoturbidimetric | g/L | 0.9-2 | 0.9-2 | 3 | Yes | Yes | Yes | Yes | Yes | ||
90.06.5 | ALPHA AMYLASE ISOENZYMES PANCREATIC FRACTION | SERVICE | Colorimetric | U/L | 13-53 | 13-53 | 3 | Yes | Yes | Yes | Yes | Yes | ||
90.06.1 | ALPHA1 ACID GLYCOPROTEIN | SERVICE | Immunoturbidimetric | g/L | 0.5-1.2 | 0.5-1.2 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.05.5 | ALPHA-FETOPROTEIN | SERVICE | ECLIA | ug/L | <7.0 | < 7.0 not pregnant_x000D_ 14th Sept. :25.3_x000D_ 15th Sept. :29.0_x000D_ 16th Sept. :33.3_x000D_ 17th Sept. :38.3_x000D_ 18th Sept. :44.0 | 1 | Yes | Yes | Yes | Yes | Yes | ||
90.07.1 | ALUMINIUM | SERVICE | ICP-MS | ug/L | <10.0 | <10.0 | 5 | Yes | Yes | Yes | Yes | Yes | ||
90.07.5 | AMMONIUM | SERVICE | Enzymatic | ug/dL | 27-102 | 18-87 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.08.1 | ANDROSTENEDIOL-GLUCURONIDE | SERVICE | ELISA | ug/L | 1.53-14.82 | pre menopause 0.55-4.64_x000D_ post menopause 0.61-3.71 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.08.2 | ANGIOTENSIS II - SOA | SERVICE | RIA | pmol/L | 19.0-38.0 | 19.0-38.0 | 15 | Yes | Yes | Yes | Yes | Yes | ||
90.49.3 | ANTIBODIES AGAINST ERYTHROCYTES: INDIRECT COOMBS TEST | SERVICE | Hemagglutination | negative | negative | 2 | Yes | Yes | Yes | Yes | Yes | |||
90.08.4 | APOLIPOPROTEIN A1 | SERVICE | Nephelometric | g/L | 1.10-1.70 | 1.20-1.90 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.08.5 | APOLIPOPROTEIN B | SERVICE | Nephelometric | g/L | 0.80-1.55 | 0.75-1.50 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.09.1 | HAPTOGLOBIN | SERVICE | Immunoturbidimetric | g/L | 0.3-2.00 | 0.3-2.00 | 3 | Yes | Yes | Yes | Yes | Yes | ||
90.49.6 | B2-GLYCOPROTEIN I AB (GPI) IGG | SERVICE | Chemiluminescence | CU | <20.0 absent | <20.0 absent | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.49.6 | B2-GLYCOPROTEIN I AB (GPI) IGM | SERVICE | Chemiluminescence | CU | <20.0 absent | <20.0 absent | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.10.1 | BETA 2 MICROGLOBULIN IN URINE | SERVICE | Chemiluminescence | ug/L | 0-278 | 0-278 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.10.1 | BETA 2 SIERICA MICROGLOBULIN | SERVICE | Immunoturbidimetric | mg/L | male < 60 yr: 0.8-2.4_x000D_ male > 60 yr: < 3.0 | woman < 60 years: 0.8-2.4_x000D_ woman > 60 years: < 3.0 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.10.2 | BICARBONATES | SERVICE | Enzymatic | mmol/L | 23-32 | 23-32 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.11.1 | C PEPTIDE | SERVICE | ECLIA | ug/L | 1.1 - 4.4 | 1.1 - 4.4 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.55.1 | CA 125 (CARBOHYDRATE ANTIGEN 125) | SERVICE | ECLIA | kUI/L | < 35 | < 35 | 1 | Yes | Yes | Yes | Yes | Yes | ||
90.55.2 | CA 15.3 (CARBOHYDRATE ANTIGEN 15.3) | SERVICE | ECLIA | kUI/L | < 35 | < 35 | 1 | Yes | Yes | Yes | Yes | Yes | ||
90.55.3 | CA 19.9 (CARBOHYDRATE ANTIGEN 19.9) | SERVICE | ECLIA | kUI/L | < 34 | < 34 | 1 | Yes | Yes | Yes | Yes | Yes | ||
90.11.7 | IONIZED CALCIUM | SERVICE | Potentiometric | mmol/L | 1.1-1.3 | 1.1-1.3 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.11.4 | TOTAL CALCIUM IN URINE | SERVICE | Colorimetric | mg/dL | 5-30 | 5-30 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.11.4 | TOTAL CALCIUM IN URINE 24 HOURS | SERVICE | Colorimetric | mg/24h Diuresi: mL | 10.0-300.0 | 10.0-300.0 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.11.5 | CALCITONIN | SERVICE | ECLIA | ng/L | <14.30 | <9.82 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.58.4 | INTRAERYTHROCYTE CARBOXYHEMOGLOBIN | SERVICE | CO-Oximeter | % | Non-smokers: up to 5.0_x000D_ Smokers: up to 10.0 | Non-smokers: up to 5.0_x000D_ Smokers: up to 10.0 | 3 | Yes | Yes | Yes | Yes | Yes | ||
90.42.6 | CARBOHYDRATE-DEFICIENT CDT TRANSFERRIN | SERVICE | Capillary Electrophoresis | % | = < 1.7 negative > 1.7 = < 2 doubt > 2.0 POSITIVE | = < 1.7 negative > 1.7 = < 2 doubt > 2.0 POSITIVE | 4 | Yes | Yes | Yes | Yes | Yes | ||
90.12.5 | CERULOPLASMIN | SERVICE | Immunoturbidimetric | g/L | 0.15-0.30 | 0.16-0.45 | 3 | Yes | Yes | Yes | Yes | Yes | ||
91.15.F | CYTOMEGALOVIRUS: IGG AND IGM ANTIBODY DETECTION (CMV REFLEX) | SERVICE | ECLIA | 3 | Yes | Yes | Yes | Yes | Yes | |||||
CITOMEGALOVIRUS AB IGG - TEST AVIDITY | SERVICE | ECLIA | Index | <45% low avidity._x000D_ 45.0-54.9% avidity gray zone: re-draw recommended within 2-4 weeks._x000D_ >=55% high avidity | <45% low avidity._x000D_ 45.0-54.9% avidity gray zone: re-draw recommended within 2-4 weeks._x000D_ >=55% high avidity | 5 | Yes | Yes | Yes | Yes | Yes | |||
CYTOMEGALOVIRUS: IGG ANTIBODY DETECTION | SERVICE | ECLIA | U/mL | < 0.5 negative 0.5-1.0 doubt > 1.0 POSITIVE | < 0.5 negative 0.5-1.0 doubt > 1.0 POSITIVE | 2 | Yes | Yes | Yes | Yes | Yes | |||
CYTOMEGALOVIRUS: IGM ANTIBODY DETECTION | SERVICE | ECLIA | Index | negative | negative | 3 | Yes | Yes | Yes | Yes | Yes | |||
90.13.3 | CHLORIDE IN URINE | SERVICE | ISE | mEq/L | 170-250 | 170-250 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.13.3 | CHLORIDE IN URINE 24 HOURS | SERVICE | ISE | mMol/24h Diuresi: mL | 110-250 | 110-250 | 2 | Yes | Yes | Yes | Yes | Yes | ||
CULTURE - ID. SHIGELLE - FECES | SERVICE | Cultivation | 3 | Yes | Yes | Yes | Yes | Yes | ||||||
90601 | COMPLEMENT C1 - INHIBITOR (ACTIVITY) | SERVICE | Enzymatic | % | > 70 | > 70 | 12 | Yes | Yes | Yes | Yes | Yes | ||
90601 | COMPLEMENT C1 - INHIBITOR (PROTEIN) | SERVICE | Nephelometric | mg/dL | 21-38 | 21-38 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.58.2 | COOMBS DIRECT TEST | SERVICE | Hemagglutination | negative | negative | 2 | Yes | Yes | Yes | Yes | Yes | |||
90.15.3 | CORTISOL IN URINE 24 HOURS | SERVICE | Chemiluminescence | ug/24h Diuresi: mL | 30-350 | 30-350 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.15.3 | SERUM CORTISOL | SERVICE | ECLIA | ug/dL | 6.02-18.40 | 6.02-18.40 | 2 | Yes | Yes | Yes | Yes | Yes | ||
CREATIN KINEINASE ISOENZYME MB (CK-MB) | SERVICE | ECLIA | ug/L | < 3.61 | < 4.67 | 1 | Yes | Yes | Yes | Yes | Yes | |||
90.17.2 | DEHYDROEPIANDROSTERONE SULFATE (DEA-S) | SERVICE | ECLIA | ug/dL | 1 - 4 yr 0.47-19.4 4 - 9 yr 2.8-85 9 - 14 yr 24.4-247 14 - 19 yr 70.2-492 19 - 24 yr 211-492 24 - 44 yr 90-449 44 - 54 yr 44.30-331 54 - 64 yr 51.7-295 64 - 74 yr 33.6-249 75 - 120 yr 16.2-123 | 1 - 4 yr 0.47-19.4 4 - 9 yr 2.8-85 9 - 14 yr 33.9-280 14 - 19 yr 65.1-368 19 - 24 yr 148-407 24 - 44 yr 61-340 44 - 54 yr 35.4-256 54 - 64 yr 18.9-205 64 - 74 yr 9.4-246 74 - 120 yr 12-154 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.17.2 | DHEA (DEHYDROEPIANDROSTERONE) | SERVICE | ELISA | #N/A | ug/L | 0.06-13.37 | 0.06-12.21 | 4 | Yes | Yes | Yes | Yes | Yes | |
90.17.5 | DHT (DIHYDROTESTOSTERONE) | SERVICE | ELISA | ng/L | 1 - 9 yr < 85.7 9 - 14 yr 11.1-875.6 14 - 18 yr 70.0-1260.9 18 - 84 yr 143-842 84 - 120 yr For ages over 84 years, no reference values are available | 2 - 9 yr < 88.9 9 - 14 yr 22.5-280.6 14 - 18 yr 62.6-760.3 18 - 49 yr < 596 49 - 87 yr < 431 87 - 120 yr For ages over 87 years, no reference values are available | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.21.1 | DIGOXIN | SERVICE | ECLIA | mg/L | Therapeutic range 0.6-1.2 toxicity: > 2.0 | Therapeutic range 0.6-1.2 toxicity: > 2.0 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.39.1 | URINE PROTEIN ELECTROPHORESIS | SERVICE | Agarose gel electrophoresis | 5 | Yes | Yes | Yes | Yes | Yes | |||||
90.39.1 | 24H URINE PROTEIN ELECTROPHORESIS | SERVICE | Agarose gel electrophoresis | Yes | Yes | Yes | Yes | Yes | ||||||
91.39.4 | URINE CYTOLOGICAL EXAMINATION | SERVICE | Papanicolaou staining | 18 | Yes | Yes | Yes | Yes | Yes | |||||
90.21.3 | FECES CHEMICAL AND MICROSCOPIC EXAMINATION (FATS, PROD. BY DIGES) | SERVICE | Microscopic | 3 | Yes | Yes | Yes | Yes | Yes | |||||
90.24.2 | PROSTATIC ACID PHOSPHATASE (PAP) | SERVICE | Chemiluminescence | ug/L | < 3 | < 3 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.23.4 | PHOSPHATE ACIDA | SERVICE | Colorimetric | U/L | < 6.6 | < 6.5 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.24.1 | ALKALINE PHOSPHATASE BONE ISOENZYME | SERVICE | Chemiluminescence | ug/L | 6- 30 | 6 - 26 | 4 | Yes | Yes | Yes | Yes | Yes | ||
90.24.3 | INORGANIC PHOSPHATE IN URINE | SERVICE | Colorimetric | g/L | 0.3-1 | 0.3-1 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.24.3 | INORGANIC PHOSPHATE IN 24-HOUR URINE | SERVICE | Colorimetric | g/24H diuresi: mL | 0.4-1.3 | 0.4-1.3 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.60.2 | COMPLEMENT FRACTION C4 | SERVICE | Immunoturbidimetric | g/L | 0.1-0.4 | 0.1-0.4 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.60.2 | FRACTION C1Q OF COMPLEMENT | SERVICE | Nephelometric | mg/dL | 10 - 25 | 10 - 25 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.60.2 | FRACTION C3 OF THE COMPLEMENT | SERVICE | Immunoturbidimetric | g/L | 0.9-1.8 | 0.9-1.8 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.49.7 | GAD AB (GLUTAMINE DECARBOXYLASE) | SERVICE | Chemiluminescence | IU/mL | max 30 | max 30 | 3 | Yes | Yes | Yes | Yes | Yes | ||
90.27.1 | GLUCOSE IN URINE 24 H | SERVICE | Enzymatic | mg/24h Diuresi: mL | absent | absent | 2 | Yes | Yes | Yes | Yes | Yes | ||
90272 | ERYTHROCYTE GLUCOSE-6-P-DH (G6PDH) | SERVICE | Spectrophotometric | U/g Hb | normal males >=9.52_x000D_ deficient males: 01-2.71_x000D_ max 30 | normal females >=10.22_x000D_ deficient females 0.1-2.95_x000D_ heterozygous females 3.55-10.22_x000D_ max 30 | 4 | Yes | Yes | Yes | Yes | Yes | ||
BLOOD GROUP ABO RH (D) | SERVICE | Hemagglutination | 2 | Yes | Yes | Yes | Yes | Yes | ||||||
91.16.B | HBV - HEPATITIS B DNA (HBV DNA) (S REGION) | SERVICE | Real Time PCR | Not detected/detected | Not detected/detected | 18 | Yes | Yes | Yes | Yes | Yes | |||
91.16.B | HBV - HEPATITIS B DNA QUANTIZATION (HBV DNA Q) | SERVICE | Real Time PCR | UI/mL | Serum Sensitivity: 2.4 IU/ml_x000D_ Plasma Sensitivity: 2.7 IU/ml_x000D_ Specificity: >99.9%_x000D_ Genotype: A-H, predominant pre-core mutant_x000D_ Linearity: 10-1,000,000,000 IU/ml | Serum Sensitivity: 2.4 IU/ml_x000D_ Plasma Sensitivity: 2.7 IU/ml_x000D_ Specificity: >99.9%_x000D_ Genotype: A-H, predominant pre-core mutant_x000D_ Linearity: 10-1,000,000,000 IU/ml | 18 | Yes | Yes | Yes | Yes | Yes | ||
91.19.R | HCV - HEPATITIS C VIRUS - REFLEX | Comprende i codici 91.19.5, 91.19.4, 91.20.2 | SERVICE | 18 | Yes | Yes | Yes | Yes | Yes | |||||
91.19.5 | HEPATITIS C VIRUS (HCV) ANTIBODY | SERVICE | ECLIA | negative | negative | 2 | Yes | Yes | Yes | Yes | Yes | |||
91.19.4 | HCV - HEPATITIS C RNA QUANTITATIVE (HCV RNA Q) | SERVICE | Real Time PCR | UI/mL | Serum Sensitivity: 9.61 IU/ml_x000D_ Plasma Sensitivity: 8.46 IU/ml_x000D_ Specificity: >99.9% Genotypes: 1-6_x000D_ Linearity: 15-100,000,000 IU/ml | Serum Sensitivity: 9.61 IU/ml_x000D_ Plasma Sensitivity: 8.46 IU/ml_x000D_ Specificity: >99.9% Genotypes: 1-6_x000D_ Linearity: 15-100,000,000 IU/ml | 18 | Yes | Yes | Yes | Yes | Yes | ||
91.20.2 | HCV - HEPATITIS C RNA TYPING (HCV RNA T) | SERVICE | PCR + Hybridization Method | UI/mL | Sensitivity limit of the method: 2000 IU/ml | Sensitivity limit of the method: 2000 IU/ml | 18 | Yes | Yes | Yes | Yes | Yes | ||
91.19.3 | HCV - HEPATITIS C RNA (HCV RNA) | SERVICE | Real Time PCR | Not detected/detected | Not detected/detected | 18 | Yes | Yes | Yes | Yes | Yes | |||
91.23.F | HIV 1-2 AB | SERVICE | ECLIA | Index | negative | negative | 2 | Yes | Yes | Yes | Yes | Yes | ||
HIV1 - HIV2 AB (W.B.) | SERVICE | Immunoblotting | 5 | Yes | Yes | Yes | Yes | Yes | ||||||
GP36 (HIV-2 ENV) | ||||||||||||||
GP140 (HIV-2 ENV | ||||||||||||||
P31 (HIV-1 POL) | ||||||||||||||
GP160 (HIV-1 ENV) | ||||||||||||||
P24 (HIV-1 GAG) | ||||||||||||||
GP41 (HIV-1 ENV) | ||||||||||||||
HIV1 - HIV-2 AB IGG - 2 TEST | SERVICE | ELFA/Chemiluminescence | 2 | Yes | Yes | Yes | Yes | Yes | ||||||
Chemioluminescenza (ENV HIV1 e HIV2, CORE HIV1) | Index | <1.0 negative >=1.0 POSITIVE | <1.0 negative >=1.0 POSITIVE | |||||||||||
ELFA (AG p24 e GP41 ENV HIV1 - GP36 ENV HIV2) | Index | <0.25 negative >=0.25 POSITIVE | <0.25 negative >=0.25 POSITIVE | |||||||||||
91.24.9 | HPV - PAPILLOMA VIRUS DNA (HPV DNA) | SERVICE | Real Time PCR | Not detected/detected | Not detected/detected | 18 | Yes_x000D_ Only by Reservation | No | No | No | No | |||
91.24.C | HPV - PAPILLOMA VIRUS DNA TYPING (HPV-DNA TIPIZ.) | SERVICE | Real Time PCR | 18 | Yes_x000D_ Only by Reservation | No | No | No | No | |||||
90.69.2 | IMMUNOFIXATION IN URINE | SERVICE | Immunofixation | 7 | Yes | Yes | Yes | Yes | Yes | |||||
90.29.1 | INSULIN | SERVICE | ECLIA | uU/mL | 2.6-24.9 | 2.6-24.9 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90511 | INSULIN AB (AIAA) | SERVICE | Chemiluminescence | IU/mL | < 20.0 | < 20.0 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.32.2 | LITHIUM | SERVICE | Colorimetric | mmol/L | 0.60-1.20 toxicity: > 2.0 | 0.60-1.20 toxicity: > 2.0 | 3 | Yes | Yes | Yes | Yes | Yes | ||
90.38.8 | MACROPROLACTIN | SERVICE | Electrochemiluminescence | 4 | Yes | Yes | Yes | Yes | Yes | |||||
90.32.5 | TOTAL MAGNESIUM IN URINE | SERVICE | Colorimetric | mg/giorno | 73-121.5 | 73-121.5 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.32.5 | TOTAL MAGNESIUM IN 24-HOUR URINE | SERVICE | Colorimetric | mg/24h | 73.0-121.5 | 73.0-121.5 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.52.4 | AB CORE (ANA TEST) (titer and pattern) | SERVICE | IF test - Hep-2 substrate | Title:< 1:80 absent 1:80 - 1:160 low 1:320 - 1:640 high > 1:640 very high | Title:< 1:80 absent 1:80 - 1:160 low 1:320 - 1:640 high > 1:640 very high | 5 | Yes | Yes | Yes | Yes | Yes | |||
90346 | HOMOCYSTEINE | SERVICE | Enzymatic | <13 | <13 | 2 | Yes | Yes | Yes | Yes | Yes | |||
LIQUID PHASE PAP TEST | SERVICE | Papanicolaou staining | 10 | Only by Reservation_x000D_ in association with a gynecological viYest | No | No | No | No | ||||||
90355 | PARATHYROID HORMONE (INTACT PTH) | SERVICE | ECLIA | ng/L | 15-65 | 15-65 | 2 | Yes | Yes | Yes | Yes | Yes | ||
91.25.8 | PARVOVIRUS B19 AB IGG E IGM | SERVICE | Chemiluminescence | Yes | Yes | Yes | Yes | Yes | ||||||
PARVOVIRUS B19 AB IGG | SERVICE | Chemiluminescence | IU/mL | < 2.0 negative 2.0 - 2.49 doubt >= 2.5 POSITIVE | < 2.0 negative 2.0 - 2.49 doubt >= 2.5 POSITIVE | 2 | Yes | Yes | Yes | Yes | Yes | |||
PARVOVIRUS B19 AB IGM | SERVICE | Chemiluminescence | Index | negative | negative | 2 | Yes | Yes | Yes | Yes | Yes | |||
90.36.6 | TYPE B NATRIURETIC PEPTIDE (NT PRO-BNP) | SERVICE | ECLIA | ng/L | healthy subjects <125 unlikely acute heart failure_x000D_ <50 years: 300-450_x000D_ 50-75 years: 300-900_x000D_ >75 years: 300-1800_x000D_ likely acute heart failure_x000D_ <50 years: >450_x000D_ 50-75 years: >900_x000D_ >75 years: >1800 | healthy subjects <125 unlikely acute heart failure_x000D_ <50 years: 300-450_x000D_ 50-75 years: 300-900_x000D_ >75 years: 300-1800_x000D_ likely acute heart failure_x000D_ <50 years: >450_x000D_ 50-75 years: >900_x000D_ >75 years: >1800 | 3 | Yes | Yes | Yes | Yes | Yes | ||
90.37.4 | POTASSIUM IN URINE | SERVICE | ISE | mEq/L | 25-100 | 25-100 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.37.4 | POTASSIUM IN THE URINE OF 24 H | SERVICE | ISE | mMol/24h | 25-125 | 25-125 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.37.6 | PREALBUMIN | SERVICE | Immunoturbidimetric | g/L | 0.2-0.4 | 0.2-0.4 | 3 | Yes | Yes | Yes | Yes | Yes | ||
(vuoto) | PROCALCITONIN (PCT) | SERVICE | ECLIA | ug/L | < 0.046 Clinical Cut Off | < 0.046 Clinical Cut Off | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.38.1 | PROGESTERONE | SERVICE | ECLIA | ug/L | 0.05-0.149 | Postmenopause: 0.50-0.126_x000D_ Follicular phase: 0.050-0.193_x000D_ Ovulatory phase: 0.055-4.14_x000D_ Luteal phase:4.11-14.5 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90722 | PROTEIN C COAGULASE | SERVICE | Coagulometric | % | 80.5-150.0 | 80.5-150.0 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.38.5 | PROTEIN IN URINE | SERVICE | Enzymatic | mg/L | < 150 | < 150 | 3 | Yes | Yes | Yes | Yes | Yes | ||
90.38.5 | PROTEIN IN URINE 24 H | SERVICE | Enzymatic | mg/24h Diuresi: mL | < 150 | < 150 | 3 | Yes | Yes | Yes | Yes | Yes | ||
90535 | TSH AB RECEPTORS | SERVICE | ECLIA | IU/L | <1.75 | <1.75 | 4 | Yes | Yes | Yes | Yes | Yes | ||
90772 | PROTEIN C RESISTANCE - APC RESISTANCE | SERVICE | Coagulometric | Ratio | Genotype negative > 2.6_x000D_ heterozygous 1.3-1.7_x000D_ homozygous 1.0 | Genotype negative > 2.6_x000D_ heterozygous 1.3-1.7_x000D_ homozygous 1.0 | 3 | Yes | Yes | Yes | Yes | Yes | ||
90.74.5 | RETICULOSITES: COUNTING | SERVICE | Hematology Analyzer | % | 0.7-2.8 | 0.7-2.8 | 1 | Yes | Yes | Yes | Yes | Yes | ||
91.26.9 | ROTAVIRUS ANTIGENS DIRECT SEARCH IN THE STOOL | SERVICE | Immunochromatographic | present/absent | present/absent | 2 | Yes | Yes | Yes | Yes | Yes | |||
90.40.4 | URINARY SODIUM | SERVICE | ISE | mEq/L | 50-200 | 50-200 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.40.4 | URINARY SODIUM 24H | SERVICE | ISE | mMol/24h | 40-220 | 40-220 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.41.3 | TESTOSTERONE | SERVICE | ECLIA | ug/L | 20 - 49 yr 2.49-8.36_x000D_ 49 - 120 yr 1.93-7.4_x000D_ 2-20 yr < 20 yr: no reference values available | 20 - 49 yr 0.084-0.481_x000D_ 49 - 120 yr 0.029-0.408_x000D_ 2 - 20 yr < 20 yr: no reference values available | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.41.4 | TESTOSTERONE FREE | SERVICE | Chemiluminescence | ng/L | 18-39 years: 12.3-46.6 40-59 years: 9.57-40.6 >=60 years: 7.72-31.4 | 18-39 years: <5.45 >=40 years: <4.43 | 3 | Yes | Yes | Yes | Yes | Yes | ||
91.47.C | LYMPH TYPE-CD16 (CD16+/CD56+/CD3-) (NK LYMPHOCYTES) | SERVICE | Flow cytometry | % cell/uL | 6-31 134-744 | 6-31 134-744 | 3 | Yes | Yes | Yes | Yes | Yes | ||
91.47.C | LYMPH TYPE-CD19 (CD19+/CD3-) (B TOTAL LYMPHOCYTES) | SERVICE | Flow cytometry | % cell/uL | 5-15 120-360 | 5-15 120-360 | 3 | Yes | Yes | Yes | Yes | Yes | ||
91.47.C | LYMPH TYPE-CD20 (CD20+/CD3-) (B TOTAL LYMPHOCYTES) | SERVICE | Flow cytometry | % | 5 - 12 | 5 - 12 | 3 | Yes | Yes | Yes | Yes | Yes | ||
91.47.C | LYMPH TYPE-CD25 (LYMPH. WITH REC. IL2) | SERVICE | Flow cytometry | % | 15-40 | 15-40 | 3 | Yes | Yes | Yes | Yes | Yes | ||
91.47.C | LYMPH TYPE.-CD3 (CD3+) (T TOTAL LYMPHOCYTES) | SERVICE | Flow cytometry | % cell/uL | 59-85 1416-2040 | 59-85 1416-2040 | 3 | Yes | Yes | Yes | Yes | Yes | ||
91.47.C | LYMPH TYPE-CD4 (CD4+/CD3+) (T HELPER-INDUCER) | SERVICE | Flow cytometry | % cell/uL | 29-61 696-1464 | 6-31 134-744 | 3 | Yes | Yes | Yes | Yes | Yes | ||
91.47.C | LYMPH TYPE-CD57 | SERVICE | Flow cytometry | % | 13-27 | 13-27 | 3 | Yes | Yes | Yes | Yes | Yes | ||
91.47.C | LYMPH TYPE-CD8 (CD8+/CD3+) (T SUPPRESSOR-CYTOTOXIC) | SERVICE | Flow cytometry | % cell/uL | 11-38 264-912 | 11-38 264-912 | 3 | Yes | Yes | Yes | Yes | Yes | ||
91.47.C | ACTIVATED T-LINK TYPE (HLA DR+/CD3+) | SERVICE | Flow cytometry | % cell/uL | 2-14 24-210 | 2-14 24-210 | 3 | Yes | Yes | Yes | Yes | Yes | ||
90.54.4 | THYROGLOBULIN AB | SERVICE | ECLIA | IU/mL | < 115 | < 115 | 1 | Yes | Yes | Yes | Yes | Yes | ||
90.41.5 | THYROGLOBULIN (TG) | SERVICE | ECLIA | ug/L | 3.5/77.0 | 3.5/77.0 | 1 | Yes | Yes | Yes | Yes | Yes | ||
90.51.4 | THYROPEROXIDASE AB (TPO) | SERVICE | ECLIA | IU/mL | <34 | <34 | 1 | Yes | Yes | Yes | Yes | Yes | ||
TOXOPLASMA GONDII AB IGG | SERVICE | ECLIA | IU/mL | < 1.0 negative 1-30 dubbio > 30 POSITIVE | < 1.0 negative 1-30 dubbio > 30 POSITIVE | 4 | ||||||||
91.09.D | TOXOPLASMA GONDII AB IGG e IGM (+ ev. AVIDITY) | SERVICE | ECLIA | IU/mL | negative | negative | 2 | |||||||
TOXOPLASMA GONDII AB IGM | SERVICE | ECLIA | Index | negative | negative | 4 | ||||||||
90.53.D | TRANSGLUTAMINE AB IGA | SERVICE | Chemiluminescence | CU | <20 absent | <20 absent | 4 | Yes | Yes | Yes | Yes | Yes | ||
90.53.D | TRANSGLUTAMINE AB IGG | SERVICE | Chemiluminescence | CU | <20 absent | <20 absent | 4 | Yes | Yes | Yes | Yes | Yes | ||
90.53.D | TRANSGLUTAMINE Ab REFLEX | SERVICE | Chemiluminescence | 4 | Yes | Yes | Yes | Yes | Yes | |||||
90.82.3 | TROPONIN I | SERVICE | ELFA | mg/L | < 25 | < 25 | 1 | Yes | Yes | Yes | Yes | Yes | ||
90.82.3 | TROPONIN T | SERVICE | ECLIA | ng/L | < 14 | < 14 | 1 | Yes | Yes | Yes | Yes | Yes | ||
90.44.1 | UREA 24-HOUR URINE CLEARANCE | SERVICE | Enzymatic | ml/min | 40-90 | 40-90 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.44.1 | UREA NELLE URINE | SERVICE | Enzymatic | g/L | 10- 30 | 10- 30 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.44.1 | UREA IN URINE 24 H | SERVICE | Enzymatic | g/24h | 12-20 | 12-20 | 2 | Yes | Yes | Yes | Yes | Yes | ||
91.17.6 | HEPATITIS A VIRUS (HAV): TOTAL ANTIBODY DETECTION | SERVICE | ECLIA | Index | negative | negative | 2 | Yes | Yes | Yes | Yes | Yes | ||
HEPATITIS A VIRUS (HAV) IGM ANTIBODIES | SERVICE | ECLIA | Index | negative | negative | 2 | Yes | Yes | Yes | Yes | Yes | |||
91.18.6 | HEPATITIS B VIRUS (HBV) - REFLEX | SERVICE | ||||||||||||
HEPATITIS B VIRUS (HBV): RESEARCH FOR HBCAG (HBCAB) ANTIBODY | SERVICE | ECLIA | Index | negative | negative | 2 | Yes | Yes | Yes | Yes | Yes | |||
91.18.2 | HEPATITIS B VIRUS (HBV): RESEARCH FOR HBEAG ANTIBODY (HBEAB) | SERVICE | ECLIA | Index | negative | negative | 2 | Yes | Yes | Yes | Yes | Yes | ||
91.18.3 | HEPATITIS B VIRUS (HBV): RESEARCH FOR HBSAG (HBSAB) ANTIBODY | SERVICE | ECLIA | IU/L | <10.0 negative >/= 10 POSITIVE | <10.0 negative >/= 10 POSITIVE | 2 | Yes | Yes | Yes | Yes | Yes | ||
HEPATITIS B VIRUS (HBV): RESEARCH FOR IGM HBCAG (HBCAB IGM) ANTIBODY | SERVICE | ECLIA | Index | negative | negative | 2 | Yes | Yes | Yes | Yes | Yes | |||
91.18.4 | HEPATITIS B VIRUS (HBV): HBEAG RESEARCH | SERVICE | ECLIA | Index | negative | negative | 2 | Yes | Yes | Yes | Yes | Yes | ||
91.18.5 | HEPATITIS B VIRUS (HBV): HBSAG RESEARCH | SERVICE | ECLIA | Index | negative | negative | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.45.2 | VITAMIN A | SERVICE | HPLC | ug/dL | 30-80 | 30-80 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.45.1 | VITAMIN B1 (THIAMINE) | SERVICE | HPLC | ug/dL | 28-85 | 28-85 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90451 | VITAMIN B2 (FAD) | SERVICE | HPLC | ug/dL | 137-370 | 137-370 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90451 | VITAMIN B6 | SERVICE | HPLC | ug/dL | 8.7-27.2 | 8.7-27.2 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90451 | VITAMIN C | SERVICE | HPLC | mg/L | 4.6-14.9 | 4.6-14.9 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.44.5 | VITAMIN D ( 1,25 OH) | SERVICE | Chemiluminescence | ng/L | 20-80 | 20-80 | 4 | Yes | Yes | Yes | Yes | Yes | ||
90452 | VITAMIN E | SERVICE | HPLC | ug/dL | 500-1800 | 500-1800 | 7 | Yes | Yes | Yes | Yes | Yes | ||
ABO | ||||||||||||||
RH | ||||||||||||||
C | ||||||||||||||
E | ||||||||||||||
DWEAK | ||||||||||||||
Iga | Chemiluminescence | mg/dL | >35 Normal | >35 Normal | ||||||||||
Transglutaminas Ab IgA | Chemiluminescence | CU | <20 absent | <20 absent | ||||||||||
Endomisio Ab Iga (IFA) | Chemiluminescence | titolo | < 1:10 absent | < 1:10 absent | ||||||||||
Transglutaminas Ab Igg | Chemiluminescence | CU | <20 absent | <20 absent | ||||||||||
Gliadina Deamidata Ab IgA | Chemiluminescence | CU | <20 absent | <20 absent | ||||||||||
Gliadina Deamidata Ab IgG | Chemiluminescence | CU | <20 absent | <20 absent | ||||||||||
TOTAL PROLACTIN | ug/L | 4.04-15.20 | 4.79-23.30 | |||||||||||
PERCENTAGE RECOVERY (R%) | % | >60 | >60 | |||||||||||
90.94.3 | ES. FECAL CULTURE (INCL. IDENTIFICATION AND ATB) | SERVICE | Cultivation | negative/POSITIVE | negative/POSITIVE | 3 | Yes | Yes | Yes | Yes | Yes | |||
90.98.4 | MYCOLOGICAL EXAMINATION ON NAIL FRAGMENTS | SERVICE | Cultivation | negative/POSITIVE | negative/POSITIVE | 20 | Yes | No | No | No | No | |||
91.08.4 | STREPTOCOCCUS AGALACTIAE ES CULTURE: VAGINO-RECTAL TAMP INCL ATB | SERVICE | Cultivation | negative/POSITIVE | negative/POSITIVE | 3 | Yes_x000D_ Only by Reservation | No | No | No | No | |||
91.27.5 | YERSINIA: ES. FECAL CULTURE (INCL. IDENTIFICATION AND ANTIBIOGRAM) | SERVICE | Cultivation | 8 | Yes | Yes | Yes | Yes | Yes | |||||
90.35.3 | OXALIC ACID -URINE 24H | SERVICE | Enzymatic-colorimetric | mg/24h Diuresi: mL | 7- 44 | 4-31 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.17.B | VALPROIC ACID | SERVICE | Immunoenzyme | mg/L | 50-100_x000D_ > 100 Possible toxicity | 50-100_x000D_ > 100 Possible toxicity | 2 | Yes | Yes | Yes | Yes | Yes | ||
VANILMANDELIC ACID (VMA) -URINE 24H | SERVICE | Chromatographic-colorimetric | mg/24h Diuresi: mL | <6.6 | <6.6 | 7 | Yes | Yes | Yes | Yes | Yes | |||
90.15.2 | ACTH | SERVICE | Chemiluminescence | ng/L | 5 - 50 | 5 - 50 | 3 | Yes | Yes | Yes | Yes | Yes | ||
90.51.6 | ANTI-MYELOPEROXIDASE (MPO) ANTIBODIES | SERVICE | Chemiluminescence | UA/ml | <20 absent | <20 absent | 5 | Yes | Yes | Yes | Yes | Yes | ||
44.19.2 | BREATH TEST FOR HELYCOBACTER PYLORI (UREA C13) | SERVICE | Gas chromatographic | 12 | Yes_x000D_ Only by Reservation | No | No | No | No | |||||
C3 PROACTIVATOR - SOA | SERVICE | Turbidimetric | mg/dL | 23.4-53.3 | 23.4-53.3 | 7 | Yes | Yes | Yes | Yes | Yes | |||
CA 72-4 | SERVICE | ECLIA | U/mL | < 6.9 | < 6.9 | 3 | Yes | Yes | Yes | Yes | Yes | |||
90.12.A | CALPROTECTIN -FAECES | SERVICE | Chemiluminescence | ug/gf | < 50 | < 50 | 5 | Yes | Yes | Yes | Yes | Yes | ||
90.84.8 | CAMPYLOBACTER AG -FECES | SERVICE | Immunochromatographic | 2 | Yes | Yes | Yes | Yes | Yes | |||||
90.17.B | CARBAMAZEPINE | SERVICE | Immunological | mg/L | 4.0-12.0 | 4.0-12.0 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.47.5 | CARDIOLIPIN AB IGG | SERVICE | Chemiluminescence | CU | <20 absent | <20 absent | 4 | Yes | Yes | Yes | Yes | Yes | ||
90.47.5 | CARDIOLIPIN AB IGM | SERVICE | Chemiluminescence | CU | <20 absent | <20 absent | 4 | Yes | Yes | Yes | Yes | Yes | ||
90.03.6 | FRACTIONATED CATECHOLAMINES -URINE 24H | SERVICE | HPLC | ug/24h Diuresi: mL | 2.5 -33 | 2.5 -33 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.03.6 | PLASMA CATECHOLAMINES | SERVICE | HPLC | ng/L | 10-196 | 10-196 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90481 | GASTRIC PARIETAL CELLS AB (PCA) | SERVICE | IF test | titolo | < 1:40 absent_x000D_ 1:40 - 1:80 low_x000D_ 1:160 - 1:320 high_x000D_ > 1:320 very high | < 1:40 absent_x000D_ 1:40 - 1:80 low_x000D_ 1:160 - 1:320 high_x000D_ > 1:320 very high | 5 | Yes | Yes | Yes | Yes | Yes | ||
90.47.F | CENTROMERO AB | SERVICE | IF test - Hep-2 substrate | titolo | < 1:80 absent_x000D_ 1:80 - 1:160 low_x000D_ 1:320 - 1:640 high_x000D_ > 1:640 very high | < 1:80 absent_x000D_ 1:80 - 1:160 low_x000D_ 1:320 - 1:640 high_x000D_ > 1:640 very high | 5 | Yes | Yes | Yes | Yes | Yes | ||
90.88.G | CHLAMYDIA PNEUMONIAE AB IGA | SERVICE | ELISA | AU/ml | < 12.0 absent_x000D_ 12.0 - 18.0 borderline_x000D_ > 18.0 present | < 12.0 absent_x000D_ 12.0 - 18.0 borderline_x000D_ > 18.0 present | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.88.G | CHLAMYDIA PNEUMONIAE IGG | SERVICE | ELISA | AU/ml | < 12.0 absent_x000D_ 12.0 - 18.0 borderline_x000D_ > 18.0 present | < 12.0 absent_x000D_ 12.0 - 18.0 borderline_x000D_ > 18.0 present | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.88.G | CHLAMYDIA PNEUMONIAE IGM | SERVICE | ELISA | index | < 0.9 absent_x000D_ 0.9 - 1.1 borderline_x000D_ > 1.1 present | < 0.9 absent_x000D_ 0.9 - 1.1 borderline_x000D_ > 1.1 present | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.88.J | CHLAMYDIA TRACHOMATIS AB IGG | SERVICE | Chemiluminescence | AU/ml | < 0.9 absent_x000D_ 0.9 - 1.1 borderline_x000D_ > 1.1 present | < 0.9 absent_x000D_ 0.9 - 1.1 borderline_x000D_ > 1.1 present | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.88.J | CHLAMYDIA TRACHOMATIS AB IGM | SERVICE | IF test | < 1:10 absent_x000D_ 1:10 - 1:40 low-medium_x000D_ > 1:40 high | < 1:10 absent_x000D_ 1:10 - 1:40 low-medium_x000D_ > 1:40 high | 7 | Yes | Yes | Yes | Yes | Yes | |||
90.17.B | CICLOSPORIN | SERVICE | ECLIA | mg/L | 100-300 | 100 -300 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90482 | PMN AB CYTOPLASM (ANCA) | SERVICE | IF su PMN | 0 | < 1:20 negative >=1:20 positive | < 1:20 negative >=1:20 positive | 5 | Yes | Yes | Yes | Yes | Yes | ||
90.47.D | CITRULLINE AB IGG (CCP) | SERVICE | Immunological | U/ml | < 17 | < 17 | 4 | Yes | Yes | Yes | Yes | Yes | ||
90.90.6 | CLOSTRIDIUM DIFFICILE AG (TOXIN A+B) - FECES | SERVICE | Immunochromatographic | 2 | Yes | Yes | Yes | Yes | Yes | |||||
91.07.6 | CULTURE - FAECES - SALMONELLA | SERVICE | Cultivation | negative/positive | negative/positive | 3 | Yes | Yes | Yes | Yes | Yes | |||
90861 | CULTURE - FECES - RIC. STAPHYLOCOCCUS AUREUS | SERVICE | Cultivation | negative/positive | negative/positive | 3 | Yes | Yes | Yes | Yes | Yes | |||
91.08.4 | CULTURE - STREPTOC. AGALACTIAE (VAGINAL/RECTAL T) | SERVICE | Cultivation | negative/positive | negative/positive | 3 | Yes_x000D_ Only by Reservation | No | No | No | No | |||
90.93.C | CULTURE - ENDOCERVICAL SWAB | SERVICE | Cultivation | negative/positive | negative/positive | 3 | Yes_x000D_ Only by Reservation | No | No | No | No | |||
90.93.5 | CULTURE - PHARYNGEAL SWAB RIC. STREPTOC. PYOGENES | SERVICE | Cultivation | negative/positive | negative/positive | 4 | Yes | No | No | No | No | |||
90.93.3 | CULTURE - RECTAL SWAB | SERVICE | Cultivation | negative/positive | negative/positive | 3 | Yes_x000D_ Only by Reservation | No | No | No | No | |||
90.93.D | CULTURE - URETHRAL SWAB | SERVICE | Cultivation | negative/positive | negative/positive | 3 | Yes_x000D_ Only by Reservation | No | No | No | No | |||
90.93.B | VAGINAL SWAB CULTURE | SERVICE | Cultivation | negative/positive | negative/positive | 3 | Yes_x000D_ Only by Reservation | No | No | No | No | |||
90.61.1 | CRYOGLOBULINS | SERVICE | Visual Inspection | % | Absent | Absent | 7 | Yes | No | No | No | No | ||
90.16.5 | CHROMIUM | SERVICE | ICP-MS | ug/dL | < 1.0 | < 1.0 | 5 | Yes | Yes | Yes | Yes | Yes | ||
90.16.6 | CHROMOGRANIN A | SERVICE | IF test | ug/L | < 102 | < 102 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.61.3 | CYFRA 21.1 | SERVICE | ECLIA | ug/L | < 2.37 | < 2.37 | 3 | Yes | Yes | Yes | Yes | Yes | ||
90.17.3 | DELTA-4-ANDROSTENEDION | SERVICE | Chemiluminescence | ug/L | 0.6 - 3.1 | 0.3 - 3.3 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.17.B | DIPHENYLHYDANTOIN | SERVICE | Kinetics/Microparticles | mg/L | 44105 | 44105 | 2 | Yes | Yes | Yes | Yes | Yes | ||
DYSBIOSIS TEST | SERVICE | HPLC - Colorimetric | ug/L | 10-20 Mild Dysbiosis_x000D_ 20-40 Moderate Dysbiosis_x000D_ > 40 Severe Dysbiosis | 10-20 Mild Dysbiosis_x000D_ 20-40 Moderate Dysbiosis_x000D_ > 40 Severe Dysbiosis | 7 | Yes | Yes | Yes | Yes | Yes | |||
90483 | NATIVE DNA AB (DNADS) | SERVICE | Chemiluminescence | IU/ml | < 27 absent_x000D_ 27-35 doubtful value_x000D_ > 35 positive | < 27 absent_x000D_ 27-35 doubtful value_x000D_ > 35 positive | 5 | Yes | Yes | Yes | Yes | Yes | ||
90.90.E | ECHINOCOCCUS AB IGG+IGM | SERVICE | IHA test | titolo | = 1:160 absent_x000D_ >/= 1:320 present | = 1:160 absent_x000D_ >/= 1:320 present | 7 | Yes | Yes | Yes | Yes | Yes | ||
9017D | PANCREATIC ELASTASE -STOOL | SERVICE | ELISA | ug/gfc | >200 normal values | >200 normal values | 10 | Yes | Yes | Yes | Yes | Yes | ||
90.66.7 | HEMOGLOBIN A2 | SERVICE | Capillary Electrophoresis | % | 2.2-3.2 | 2.2-3.2 | 3 | Yes | Yes | Yes | Yes | Yes | ||
90.66.7 | PATHOLOGICAL HAEMOGLOBINS | SERVICE | Capillary Electrophoresis | % | 2.2-3.2 | 2.2-3.2 | 3 | Yes | Yes | Yes | Yes | Yes | ||
90.47.7 | ENA - JO 1 | SERVICE | Chemiluminescence | CU | <=19.9 negative | <=19.9 negative | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.47.C | ENA - LA (SB) | SERVICE | Chemiluminescence | CU | <=19.9 negative | <=19.9 negative | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.52.5 | ENA - RNP | SERVICE | Chemiluminescence | CU | <=19.9 negative | <=19.9 negative | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.47.B | ENA - Ro60 (SS-A) | SERVICE | Chemiluminescence | CU | <=19.9 negative | <=19.9 negative | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.47.9 | ENA - SCL 70 | SERVICE | Chemiluminescence | CU | <=19.9 negative | <=19.9 negative | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.47.A | ENA - SM | SERVICE | Chemiluminescence | CU | <=19.9 negative | <=19.9 negative | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.47.3 | ENA AB (SCREENING) | SERVICE | Chemiluminescence | CU | < 20 absent | < 20 absent | 4 | Yes | Yes | Yes | Yes | Yes | ||
90.47.E | ENDOMYSUM AB IGA | SERVICE | IF test | titolo | < 1:10 absent | < 1:10 absent | 5 | Yes | Yes | Yes | Yes | Yes | ||
90.47.E | ENDOMYSUM AB IGG | SERVICE | IF test | titolo | < 1:10 absent | < 1:10 absent | 5 | Yes | Yes | Yes | Yes | Yes | ||
90.17.E | ANGIOTENSIN-CONVERTING ENZYME (ACE) | SERVICE | Enzymatic-colorimetric | U/L | 8.0-52.0 | 8.0-52.0 | 3 | Yes | Yes | Yes | Yes | Yes | ||
EPSTEIN BARR AB - EBV EARLY IGG | SERVICE | Chemiluminescence | U/mL | < 10 absent_x000D_ 10 - 40 borderline_x000D_ > 40 present | < 10 absent_x000D_ 10 - 40 borderline_x000D_ > 40 present | 2 | Yes | Yes | Yes | Yes | Yes | |||
EPSTEIN BARR AB - EBV EBNA IGG | SERVICE | Chemiluminescence | U/mL | < 5 absent_x000D_ 5 - 20 borderline_x000D_ > 20 present | < 5 absent_x000D_ 5 - 20 borderline_x000D_ > 20 present | 2 | Yes | Yes | Yes | Yes | Yes | |||
EPSTEIN BARR AB - EBV VCA IGG | SERVICE | Chemiluminescence | U/mL | < 20 absent_x000D_ 20-40 borderline_x000D_ > 40 present | < 20 absent_x000D_ 20-40 borderline_x000D_ > 40 present | 2 | Yes | Yes | Yes | Yes | Yes | |||
EPSTEIN BARR AB - EBV VCA IGM | SERVICE | Chemiluminescence | U/mL | < 20 absent_x000D_ 20-40 borderline_x000D_ > 40 present | < 20 absent_x000D_ 20-40 borderline_x000D_ > 40 present | 2 | Yes | Yes | Yes | Yes | Yes | |||
91.13.2 | EPSTEIN BARR AB IGG (EBV W.B.) | SERVICE | Western Blot | 10 | Yes | Yes | Yes | Yes | Yes | |||||
91.13.2 | EPSTEIN BARR AB IGM (EBV W.B.) | SERVICE | Western Blot | 10 | Yes | Yes | Yes | Yes | Yes | |||||
91.21.D | EPSTEIN BARR DNA (EBV DNA) - QUANTIZATION | SERVICE | Real Time PCR | copie/ml | Sensitivity: 200 copies/ml_x000D_ Linear°: 250-500000000 (or 5x10^8) | Sensitivity: 200 copies/ml_x000D_ Linear°: 250-500000000 (or 5x10^8) | 10 | Yes | Yes | Yes | Yes | Yes | ||
91.21.D | EPSTEIN BARR DNA (EBV DNA) ON SANG.EDTA | SERVICE | Real Time PCR | Sensitivity: 200 copies/ml | Sensitivity: 200 copies/ml | 10 | Yes | Yes | Yes | Yes | Yes | |||
90.18.5 | ERYTHROPOIETIN SERUM | SERVICE | Chemiluminescence | mU/mL | 4.3-29.0 | 4.3-29.0 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.19.2 | ESTER (E1) | SERVICE | ELISA | ng/L | < 174 | Pre-menopause 27.1-230.6_x000D_ Post-menopause < 125.1 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.17.B | ETHOSUCCIMIDE | SERVICE | HPLC-MS/MS | mg/L | 40-100 | 40-100 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.64.3 | FACTOR II | SERVICE | Coagulometric | % | 78.4-124.0 | 78.4-124.0 | 10 | Yes | Yes | Yes | Yes | Yes | ||
90.64.3 | FACTOR IX | SERVICE | Coagulometric | % | 69.6-146.0 | 69.6-146.0 | 10 | Yes | Yes | Yes | Yes | Yes | ||
90.64.3 | FACTOR V | SERVICE | Coagulometric | % | 64-143 | 64-143 | 10 | Yes | Yes | Yes | Yes | Yes | ||
90.64.3 | FACTOR VIII | SERVICE | Coagulometric | % | 58-184 | 58-184_x000D_ not pregnant | 10 | Yes | Yes | Yes | Yes | Yes | ||
90.64.3 | X FACTOR | SERVICE | Coagulometric | % | 68.1-137.0 | 68.1-137.0 | 10 | Yes | Yes | Yes | Yes | Yes | ||
90.64.3 | FACTOR XI | SERVICE | Coagulometric | % | 73.4-149.0 | 73.4-149.0 | 10 | Yes | Yes | Yes | Yes | Yes | ||
90.64.3 | FACTOR XII | SERVICE | Coagulometric | % | 52.7-169.0 | 52.7-169.0 | 10 | Yes | Yes | Yes | Yes | Yes | ||
90.64.3 | FACTOR XIII | SERVICE | Coagulometric | % | 68-159 | 68-159 | 10 | Yes | Yes | Yes | Yes | Yes | ||
91.05.2 | FECES - REC. PARASITES | SERVICE | Microscopic | 3 | Yes | Yes | Yes | Yes | Yes | |||||
90.93.2 | FECES - SCOTCH TEST (PINWORM RESEARCH) | SERVICE | Microscopic | negative | negative | 2 | Yes | No | No | No | No | |||
90.17.B | PHENOBARBITAL | SERVICE | Kinetics/Microparticles | mg/L | 10.0-30.0 | 10.0-30.0 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.84.8 | GARDNERELLA VAGINALIS AG | SERVICE | Cultivation | 2 | Yes_x000D_ Only by Reservation | No | No | No | No | |||||
90.35.1 | GH (SOMATOTROPIC HORMONE) | SERVICE | ECLIA | ug/L | 1 - 10 yr 0.094-6.29 10 - 17 yr 0.077-10.8 21 - 77 yr 0.030-2.47 77 - 120 yr > 77 years non sono disponibili valori di riferimento 17 - 21 yr Per e° compresa tra 17 e 21 years non sono previsti valori di riferimento | 1 - 10 yr 0.120-7.79 10 - 17 yr 0.123-8.05 21 - 77 yr 0.126-9.88 77 - 120 yr > 77 years non sono disponibili valori di riferimento 17 - 21 yr Per e° compresa tra 17 e 21 years non sono previsti valori di riferimento | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.94.7 | GIARDIA AG -FECES | SERVICE | Immunochromatographic | 2 | Yes | Yes | Yes | Yes | Yes | |||||
90.49.5 | DEAMIDATED GLIADIN AB IGA | SERVICE | Chemiluminescence | CU | < 20 absent | < 20 absent | 4 | Yes | Yes | Yes | Yes | Yes | ||
90.49.5 | DEAMIDATED GLIADIN AB IGG | SERVICE | Chemiluminescence | CU | < 20 absent | < 20 absent | 4 | Yes | Yes | Yes | Yes | Yes | ||
90.25.7 | SEX HORMONE TRANSPORT GLOBULIN (SHBG) | SERVICE | ECLIA | nmol/L | male > 50 yrs: 20.6-76.7_x000D_ male 20 - 50 yrs: 18.3 - 54.1 | female > 50 years: 27.1 - 128.0_x000D_ female 20 - 50 years: 32.4 - 128.0 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90263 | GLUCAGON - SOA | SERVICE | RIA | pmol/L | < 60 | < 60 | 15 | Yes | Yes | Yes | Yes | Yes | ||
GLUTATHIONE | SERVICE | HPLC | mg/L | Not proposed. | Not proposed. | 7 | Yes | Yes | Yes | Yes | Yes | |||
91.20.7 | HDV AB | SERVICE | Chemiluminescence | AU/mL | negative | negative | 10 | Yes | Yes | Yes | Yes | Yes | ||
HE4 COMBINED OVARIAN BIOMARKERS | SERVICE | ECLIA | pmol/L | 20 - 40 yr < 60.5 40 - 60 yr < 76.0 60 - 70 yr < 83.0 70 - 120 yr < 104.0 | 7 | Yes | Yes | Yes | Yes | Yes | ||||
90.94.4 | HELICOBACTER PYLORI AB IGA | SERVICE | ELISA | U/mL | < 0.8 absent_x000D_ 0.8-1.2 doubtful value_x000D_ > 1.2 present | < 0.8 absent_x000D_ 0.8-1.2 doubtful value_x000D_ > 1.2 present | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.94.4 | HELICOBACTER PYLORI AB IGG | SERVICE | Chemiluminescence | U/mL | < 0.9 absent_x000D_ 0.9-1.1 doubtful value_x000D_ > 1.1 present | < 0.9 absent_x000D_ 0.9-1.1 doubtful value_x000D_ > 1.1 present | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.94.C | HELICOBACTER PYLORI AG -FECES | SERVICE | Immunochromatographic | 2 | Yes | Yes | Yes | Yes | Yes | |||||
91.21.B | HERPES I+II AB IGG | SERVICE | Chemiluminescence | indice | negative | negative | 4 | Yes | Yes | Yes | Yes | Yes | ||
91.21.B | HERPES I+II AB IGM | SERVICE | Chemiluminescence | indice | negative | negative | 4 | Yes | Yes | Yes | Yes | Yes | ||
91.21.B | HERPES II AB IGG | SERVICE | Chemiluminescence | indice | negative | negative | 4 | Yes | Yes | Yes | Yes | Yes | ||
91.21.B | HERPES II AB IGM | SERVICE | IF test | AU/mL | negative | negative | 4 | Yes | Yes | Yes | Yes | Yes | ||
90.78.2 | HLA TO GENOMIC TYPING | SERVICE | PCR + Hybridization Method | 20 | Yes | Yes | Yes | Yes | Yes | |||||
90.78.4 | HLA B GENOMIC TYPING | SERVICE | PCR + Hybridization Method | 20 | Yes | Yes | Yes | Yes | Yes | |||||
90.78.4 | HLA B27 DNA GENOTYPE | SERVICE | Real Time PCR | 20 | Yes | Yes | Yes | Yes | Yes | |||||
90.79.1 | HLA C GENOMIC TYPING | SERVICE | PCR + Hybridization Method | 20 | Yes | Yes | Yes | Yes | Yes | |||||
90.80.3 | HLA DQ DNA (DQ2-DQ8 CELIAC DISEASE) | SERVICE | Real Time PCR | 20 | Yes | Yes | Yes | Yes | Yes | |||||
90.67.5 | IGA SECRETORY - SALIVA | SERVICE | Nephelometric | mg/dL | 2.1-65.5 | 2.1-65.5 | 3 | Yes | Yes | Yes | Yes | Yes | ||
90.68.4 | IGG SUBCLASSES - IGG1 | SERVICE | Nephelometric | mg/dL | 382.4-928.6 | 382.4-928.6 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.68.4 | IGG SUBCLASSES - IGG2 | SERVICE | Nephelometric | mg/dL | 248.1-700.3 | 248.1-700.3 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.68.4 | IGG SUBCLASSES - IGG3 | SERVICE | Nephelometric | mg/dL | 21.81-176.06 | 21.81-176.06 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.68.4 | IGG SUBCLASSES - IGG4 | SERVICE | Nephelometric | mg/dL | 3.92-86.4 | 3.92-86.4 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.50.5 | PANCREATIC ISLAND (ICA) | SERVICE | IF test | 0 | < 1:5 absent | < 1:5 absent | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.40.7 | INTERLEUKIN 6 - IL6 | SERVICE | Chemiluminescence | mg/L | < 7.0 | < 7.0 | 7 | Yes | Yes | Yes | Yes | Yes | ||
INTOLERANCE TO HISTAMINE DAO (DIAMINE OXIDASE) | SERVICE | Real Time PCR | 10 | Yes | Yes | Yes | Yes | Yes | ||||||
90.46.5 | LAC - LUPUS ANTICOAGULANT | SERVICE | Coagulometric | negative | negative | 3 | Yes | Yes | Yes | Yes | Yes | |||
90.17.B | LAMOTRIGINE | SERVICE | HPLC-MS/MS | mg/L | 3-14 | 3-14 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.95.5 | LEGIONELLA SPP AG -URINE | SERVICE | Immunochromatographic | negative | negative | 2 | Yes | Yes | Yes | Yes | Yes | |||
LEPTIN - SOA | SERVICE | EIA | ug/L | 0 - 10 yr 2.85 - 47.8 11 - 15 yr 3.41 - 34.9 16 - 20 yr 2.57 - 22.4 | 0 - 10 yr 2.85 - 47.8 11 - 15 yr 3.41 - 34.9 | 15 | Yes | Yes | Yes | Yes | Yes | |||
90.17.B | LEVETIRACETAM (KEPPRA) | SERVICE | HPLC-MS/MS | mg/L | 10-37 | 10-37 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.30.3 | LIPOPROTEIN A - LP(A) | SERVICE | Nephelometric | nmol/L | < 75 | < 75 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.33.1 | MANGANESE | SERVICE | ICP-MS | ug/L | < 10.0 | < 10.0 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.33.3 | MERCURY | SERVICE | ICP-MS | ug/L | < 15.0 | < 15.0 | 15 | Yes | Yes | Yes | Yes | Yes | ||
89.65.1 | METAHEMOGLOBIN | SERVICE | CO-Oximeter | % | < 1.5 | < 1.5 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.51.5 | MICROSOME AB (LKM) | SERVICE | IF test | titolo | < 1:40 absent_x000D_ 1:40 - 1:80 low_x000D_ 1:160 - 1:320 high_x000D_ > 1:320 very high | < 1:40 absent_x000D_ 1:40 - 1:80 low_x000D_ 1:160 - 1:320 high_x000D_ > 1:320 very high | 5 | Yes | Yes | Yes | Yes | Yes | ||
90.51.3 | MYELIN AB (MAG) | SERVICE | ELISA | BTU | <1000 negative 1000 -4000 dubbio 4000-10000 debole positive >10000 positive | <1000 negative 1000 -4000 dubbio 4000-10000 debole positive >10000 positive | 18 | Yes | Yes | Yes | Yes | Yes | ||
90.33.5 | MYOGLOBIN | SERVICE | ECLIA | ug/L | 28-72 | 25-58 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.52.1 | MITOCHONDRIA AB (AMA) | SERVICE | Chemiluminescence | CU | =< 19.9 negative | =< 19.9 negative | 5 | Yes | Yes | Yes | Yes | Yes | ||
MONONUCLEOSIS AB (HETEROLOGOUS AB) | SERVICE | Immunochromatographic | negative | negative | 3 | Yes | Yes | Yes | Yes | Yes | ||||
91.24.F | MEASLES AB IGG | SERVICE | Chemiluminescence | AU/ml | < 13.5 absent_x000D_ 13.5-16.5 doubtful value_x000D_ >16.5 present | < 13.5 absent_x000D_ 13.5-16.5 doubtful value_x000D_ >16.5 present | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.52.2 | SMOOTH MUSCLE AB (ASMA) | SERVICE | IF test | titolo | < 1:40 absent_x000D_ 1:40 - 1:80 low_x000D_ 1:160 - 1:320 high_x000D_ > 1:320 very high | < 1:40 absent_x000D_ 1:40 - 1:80 low_x000D_ 1:160 - 1:320 high_x000D_ > 1:320 very high | 5 | Yes | Yes | Yes | Yes | Yes | ||
MUSK ANTIBODIES - SOA | SERVICE | ELISA | U/mL | < 0.4 negative | < 0.4 negative | 9 | Yes | Yes | Yes | Yes | Yes | |||
G1.01 | FACTOR II DNA MUTATION G20210A MUTATION | SERVICE | Real Time PCR | 18 | Yes | Yes | Yes | Yes | Yes | |||||
G1.01 | FACTOR V DNA MUTATION LEIDEN MUTATION | SERVICE | Real Time PCR | 18 | Yes | Yes | Yes | Yes | Yes | |||||
G1.01 | MTHFR C677T -1298A/C DNA MUTATION | SERVICE | Real Time PCR | 18 | Yes | Yes | Yes | Yes | Yes | |||||
MYCOPLASMA PNEUMONIAE AB IGG | SERVICE | Chemiluminescence | AU/ml | < 9 absent_x000D_ 9 - 10 doubtful value_x000D_ >10 present | < 9 absent_x000D_ 9 - 10 doubtful value_x000D_ >10 present | 4 | Yes | Yes | Yes | Yes | Yes | |||
MYCOPLASMA PNEUMONIAE AB IGM | SERVICE | Chemiluminescence | indice | negative | negative | 4 | Yes | Yes | Yes | Yes | Yes | |||
91.02.A | MYCOPLASMA/UREAPLASMA - CERVICAL Swab | SERVICE | Cultivation | negative | 3 | Yes_x000D_ Only by Reservation | No | No | No | No | ||||
91.02.A | MYCOPLASMA/UREAPLASMA - URETHRAL Swab | SERVICE | Cultivation | negative | negative | 3 | Yes_x000D_ Only by Reservation | No | No | No | No | |||
90.18.4 | NSE (SPECIFIC NEURONAL ENOLASE) | SERVICE | ECLIA | ug/L | < 16.3 | < 16.3 | 3 | Yes | Yes | Yes | Yes | Yes | ||
90.17.G | ANTI-MULLERIAN HORMONE (AMH). DOSAGE | SERVICE | ECLIA | ug/L | 1 - 120 yr 1.43 - 14.50 | 20 - 24 yr 1.52 - 11.7 con PCOS : 2.41 - 18.9 24 - 29 yr 1.20 - 9.85 con PCOS : 2.41 - 18.9 29 - 34 yr 0.711 - 8.13 con PCOS : 2.41 - 18.9 34 - 39 yr 0.405 - 7.49 con PCOS : 2.41 - 18.9 39 - 44 yr 0.059 - 5.47 con PCOS : 2.41 - 18.9 44 - 50 yr 0.010 - 2.71 con PCOS : 2.41 - 18.9 2 - 20 yr < 20 yr: non sono disponibili valori di riferimento 50 - 100 yr > 50 years : non sono disponibili valori di riferimento | 3 | Yes | Yes | Yes | Yes | Yes | ||
90.34.7 | OSMOLALITY/OSMOLARITY. Direct Determination | SERVICE | Auto-Osmometer | mOsm/Kg | 280-300 | 280-300 | 3 | Yes | Yes | Yes | Yes | Yes | ||
OSMOLARITY - URINE 24H | SERVICE | Auto-Osmometer | mOsm/Kg | 10-1500 | 10-1500 | 3 | Yes | Yes | Yes | Yes | Yes | |||
90354 | OSTEOCALCIN | SERVICE | ECLIA | ug/L | 18-30 yr: 24.0-70.0 > 30 yr : 14.0-46.0 | > 20 years and pre-menopause: 11.0-43.0_x000D_ post-menopause: 15.0-46.0_x000D_ women with osteoporosis: 13.0-48.0 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.17.B | OXCARBAZEPINE | SERVICE | HPLC-MS/MS | mg/L | 40-80 | 40-80 | 7 | Yes | Yes | Yes | Yes | Yes | ||
91.04.5 | PARASITES AND PROTOZOA MACRO AND MICRO-FAECES RESEARCH | SERVICE | Microscopic | 3 | Yes | Yes | Yes | Yes | Yes | |||||
91.04.6 | INTESTINAL PARASITES (HELMINTHS, PROTOZOA) -FECES | SERVICE | Microscopic | 3 | Yes | Yes | Yes | Yes | Yes | |||||
91.24.G | AB IGG PAROTITIS | SERVICE | Chemiluminescence | AU/ml | < 9 absent_x000D_ 9 - 11 doubtful value_x000D_ >11 present | < 9 absent_x000D_ 9 - 11 doubtful value_x000D_ >11 present | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.53.7 | TOTAL AB PLATELETS (IGG AND anti HLA) | SERVICE | ELISA | absent | absent | 7 | Yes | Yes | Yes | Yes | Yes | |||
90.36.3 | LEAD | SERVICE | ICP-MS | ug/dL | < 30.0_x000D_ Annual check-up: <40_x000D_ Semi-annual check-up: 41-50_x000D_ Quarterly check-up: 51-60_x000D_ Exposure reduction: >60 | < 30.0_x000D_ Annual check-up: <40_x000D_ Semi-annual check-up: 41-50_x000D_ Quarterly check-up: 51-60_x000D_ Exposure reduction: >60 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.36.3 | LEAD -URINE | SERVICE | ICP-MS | ug/grCrea | < 80.0 | < 80.0 | 7 | Yes | Yes | Yes | Yes | Yes | ||
91.08.6 | PNEUMOCOCCUS AG -URINE | SERVICE | Immunochromatographic | Negative | Negative | 2 | Yes | Yes | Yes | Yes | Yes | |||
91.49.3 | MICROBIOLOGICAL SAMPLING | In-House | Yes | Yes | Yes | Yes | Yes | |||||||
91.49.2 | VENOUS COLLECTION | In-House | Yes | Yes | Yes | Yes | Yes | |||||||
90.26.2 | THYROXINE-BINDING PROTEIN (TBG) | SERVICE | Chemiluminescence | mg/L | 13-39 | 13-39 | 2 | |||||||
90.72.4 | FREE S PROTEIN | SERVICE | Coagulometric | % | 74.6-144.0 | 68.0-132.0_x000D_ Premenopause 65.3-120.0_x000D_ Use of contraceptives 65.3-120.0 | 2 | |||||||
90.53.8 | PROTEINASE 3 AB (PR3) | SERVICE | Chemiluminescence | UA/ml | < 20 absent | < 20 absent | 5 | |||||||
90.99.1 | QUANTIFERON - TB PLUS | SERVICE | ELISA | UI/ml | <0.35 | <0.35 | 6 | Yes_x000D_ from Monday to Thursday | Yes_x000D_ from Monday to Thursday | Yes_x000D_ from Monday to Thursday | Yes_x000D_ from Monday to Thursday | Yes_x000D_ from Monday to Thursday |
||
90.39.4 | COPPER | SERVICE | Colorimetric | ug/dL | 65-165 | 65-165 | 5 | Yes | Yes | Yes | Yes | Yes | ||
90.53.4 | ACETYLCHOLINE RECEPTOR AB | SERVICE | ELISA | nmol/L | <0.45 | <0.45 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.40.2 | RENIN | SERVICE | Chemiluminescence | uU/ml | 3.3-41 | 3.3-41 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.40.2 | RENINA (ORTHOSTATISM) | SERVICE | Chemiluminescence | uU/ml | 3.3-41 | 3.3-41 | 2 | Yes | No | No | No | No | ||
RICKETTSIA CONORI AB IGM | SERVICE | IF test | < 1:64 absent | < 1:64 absent | 7 | Yes | Yes | Yes | Yes | Yes | ||||
91.07.1 | RICKETTSIE: TIT. ANTIBODIES AGAINST PROTEUS SPP. FEC. WEIL-FENIX | SERVICE | Agglutination | negative | negative | 3 | Yes | Yes | Yes | Yes | Yes | |||
91.26.E | RUBELLA AB IGG | SERVICE | ECLIA | IU/ml | < 10 negative >/= 10 positive | < 10 negative >/= 10 positive | 4 | Yes | Yes | Yes | Yes | Yes | ||
90836 | RUBELLA AB IGG - TEST AVIDITY | SERVICE | ELISA | % | < 30 bassa avidi° 30-40 media avidi° > 40 alta avidi° | 5 | Yes | Yes | Yes | Yes | Yes | |||
91.26.D | RUBELLA AB IGG and IGM | SERVICE | ECLIA | IU/ml | negative | negative | 2 | Yes | Yes | Yes | Yes | Yes | ||
RUBELLA AB IGM | SERVICE | ECLIA | Index | negative | negative | 4 | Yes | Yes | Yes | Yes | Yes | |||
91.07.3 | SALMONELLA: ANTIBODY TITRATION WITH AGGLUTINATION ACCORDING TO WIDAL | SERVICE | Agglutination | negative | negative | 5 | Yes | Yes | Yes | Yes | Yes | |||
90403 | SELENIUM | SERVICE | ICP-MS | ug/dL | 5-18.5 | 5-18.5 | 7 | Yes | Yes | Yes | Yes | Yes | ||
SIDEROCYTES/ASBESTOS | SERVICE | Coloring with Papanicolaou and Perls | 7 | Yes | Yes | Yes | Yes | Yes | ||||||
90.40.7 | SOMATOMEDIN C (IGF-1) | SERVICE | Chemiluminescence | ug/L | 1 - 4 yr 49-327 4 - 6 yr 50-297 6 - 8 yr 57-345 8 - 9 yr 74-388 9 - 10 yr 88-452 10 - 11 yr 111-551 11 - 12 yr 143-693 12 - 13 yr 183-850 13 - 14 yr 220-972 14 - 16 yr 226-996 16 - 17 yr 193-731 17 - 18 yr 163-584 18 - 20 yr 127-483 20 - 35 yr 115-358 35 - 50 yr 94-284 50 - 65 yr 75-238 65 - 80 yr 59-200 80 - 120 yr 55-166 | 1 - 4 yr 49-327 4 - 6 yr 50-297 6 - 8 yr 57-345 8 - 9 yr 74-388 9 - 10 yr 88-452 10 - 11 yr 111-551 11 - 12 yr 143-693 12 - 13 yr 183-850 13 - 14 yr 220-972 14 - 16 yr 226-996 16 - 17 yr 193-731 17 - 18 yr 163-584 18 - 20 yr 127-483 20 - 35 yr 115-358 35 - 50 yr 94-284 50 - 65 yr 75-238 65 - 80 yr 59-200 80 - 120 yr 55-166 | 2 | Yes | Yes | Yes | Yes | Yes | ||
91.08.5 | STREPTOCOCCUS: ANTI-STREPTOLYSIN-O (TAS) ANTIBODY SEARCH | SERVICE | Immunoturbidimetric | IU/mL | 0 - 14 yr < 150 14 - 120 yr < 200 | 0 - 14 yr < 150 14 - 120 yr < 200 | 2 | Yes | Yes | Yes | Yes | Yes | ||
90.17.B | TACROLIMUS (FK506) | SERVICE | ECLIA | mg/L | < 18.0 | < 18.0 | 7 | Yes | Yes | Yes | Yes | Yes | ||
90.41.6 | TELOPEPTIDES - CTX | SERVICE | ECLIA | ng/L | 5 - 30 yr 238-1019 30 - 40 yr 225-936 40 - 50 yr 182-801 50 - 60 yr 161-737 60 - 70 yr 132-752 70 - 120 yr 118-776 | 5 - 30 yr 148-967 30 - 40 yr 150-635 40 - 50 yr 131-670 POST MENOPAUSA : 177-1015 50 - 60 yr 183-1060 POST MENOPAUSA : 177-1015 60 - 70 yr 171-970 POST MENOPAUSA : 177-1015 70 - 120 yr 152-858 POST MENOPAUSA : 177-1015 | 3 | Yes | Yes | Yes | Yes | Yes | ||
91.08.B | TETANUS AB IGG (CLOSTRIDIUM TETANI TOXIN) | SERVICE | ELISA | IU/mL | < 0.1 vaccination recommended_x000D_ 0.1-0.5 booster recommended_x000D_ _x000D_ 0.6-1.0 protection: follow-up after 2_x000D_ years_x000D_ _x000D_ 1.1-5.0 long-term protection:_x000D_ follow-up after 5 years_x000D_ _x000D_ > 5.0 long-term protection:_x000D_ follow-up after 10 years | < 0.1 vaccination recommended_x000D_ 0.1-0.5 booster recommended_x000D_ _x000D_ 0.6-1.0 protection: follow-up after 2_x000D_ years_x000D_ _x000D_ 1.1-5.0 long-term protection:_x000D_ follow-up after 5 years_x000D_ _x000D_ > 5.0 long-term protection:_x000D_ follow-up after 10 years | 7 | Yes | Yes | Yes | Yes | Yes | ||
91.11.1 | TREPONEMA PALLIDUM: QUALITATIVE VDRL/PRP ANTICARDIOLIPIN ANTIBODIES | SERVICE | Flocculation | negative | negative | 3 | Yes | Yes | Yes | Yes | Yes | |||
91.11.6 | TREPONEMA PALLIDUM: QUANTITATIVE VDRL/PRP ANTICARDIOLIPIN ANTIBODIES | SERVICE | Flocculation | titolo | < 1:2 negative | < 1:2 negative | 3 | Yes | Yes | Yes | Yes | Yes | ||
91.10.5 | TREPONEMA PALLIDUM: ANTIBODIES, AGGL. INDIRECT QUANTITATIVE TPHA/TPPA | SERVICE | Hemagglutination | titolo | < 1:40 absent | < 1:40 absent | 4 | Yes | Yes | Yes | Yes | Yes | ||
91.10.B | TREPONEMA PALLIDUM: RESEARCH FOR IGG ANTIBODIES (EIA) | SERVICE | ECLIA | indice | negative | negative | 4 | Yes | Yes | Yes | Yes | Yes | ||
91.10.B | TREPONEMA PALLIDUM: RESEARCH FOR IGM ANTIBODIES (EIA) | SERVICE | ECLIA | indice | negative | negative | 4 | Yes | Yes | Yes | Yes | Yes | ||
91.10.A | TRICHOMONAS VAGINALIS (RESEARCH) | SERVICE | Microscopic | 2 | Yes | No | No | No | No | |||||
90.42.B | TRYPTASE | SERVICE | ELISA | ng/mL | < 15.0 | < 15.0 | 12 | Yes | Yes | Yes | Yes | Yes | ||
CHICKENPOX AB IGG | SERVICE | Chemiluminescence | mIU/mL | < 135 absent_x000D_ 135 - 165 borderline_x000D_ > 165 present | < 135 absent_x000D_ 135 - 165 borderline_x000D_ > 165 present | 2 | Yes | Yes | Yes | Yes | Yes | |||
CHICKENPOX AB IGM | SERVICE | Chemiluminescence | indice | negative | negative | 2 | Yes | Yes | Yes | Yes | Yes | |||
90.45.4 | ZINC | SERVICE | Colorimetric | ug/dL | 70-120 | 70-120 | 5 | Yes | Yes | Yes | Yes | Yes | ||
FAECAL ZONULIN | SERVICE | ELISA | ug/L | 15-107 | 15-107 | 15 | Yes | Yes | Yes | Yes | Yes | |||
SERUM ZONULIN | SERVICE | ELISA | ug/L | 20.0 - 48.0 | 20.0 - 48.0 | 21 | Yes | Yes | Yes | Yes | Yes |
I migliori professionisti ed esperti al servizio dei nostri pazienti
Da lunedì a venerdì:
7:00 – 19:30
Sabato:
7:00 – 12:30
Domenica: chiuso
Prelievi
Da lunedì a sabato:
7:00 – 10:00
©2025 ISTITUTO DIAGNOSTICO E FISIOTERAPICO NUOVA RISANA SRL – Società con Socio Unico | Capitale Sociale Euro 10.000,00 I.V | C.F./P.IVA 03797990128 – Via Egidio Checchi, 5/7, Gallarate, VA 21013
Accreditato Regione Lombardia Delibera Giunta Regionale n. 131 del 18/02/2009, n. 32 del 21/01/2021